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ABSTRACT 
KwaZulu-Natal province records the highest number of tuberculosis cases diagnosed 
in the country, but less than 50% of these were cured in 2008, and fewer in those 
from rural areas and informal settlements where inadequate health care continues. 
HIV and AIDS associated tuberculosis frequently require labour-intensive methods of 
monitoring and combating for any success to be achieved. The socio-economic 
context wherein these diseases occur further limit their control. 
The low proportion of tuberculosis patients currently with successful treatment 
outcomes in Umgungundlovu Health District makes essential an in-depth 
investigation to establish the factors that are associated with these poor outcomes. 
This study investigates the factors affecting the current poor treatment outcomes in 
new patients with tuberculosis in a high disease burden district of KwaZulu-Natal in 
2011. 
Methods 
A retrospective case-control study was conducted comprising 300 adult cases of 
tuberculosis who failed to complete 6 months of ambulant therapy and 300 
frequency matched controls who completed therapy. A random sample of 15 primary 
health care clinics was selected from where consecutive cases and controls were 
selected with probability proportional to the number of tuberculosis patients seen at 
the clinic. Data was extracted from patient records and interviews. Processed data 
was analysed to identify risk associations using multivariate logistic regression. 
Results 
After adjusting for confounding statistically significant risk factors associated with 
poor tuberculosis treatment outcomes were unemployment (Odds Ratio (OR) 16.0; 
95% CI: 6.7 to 37.8); living in a rural area (OR 14.3; 95% CI: 1.1 to 18), distance 
from home to clinic (OR 1.4; 95% CI: 1.3 to 1.6), living with HIV (OR 2.3; 95% CI: 1.1 
to 4.7) and being very ill (OR -5.0; 95% CI: 2.1 to 11.9).  
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Discussion 
The principal findings are that non-adherence to TB treatment is significantly 
associated with a number of non-health systems issues. Determinants of poor TB 
treatment outcomes in patients receiving six-month ambulatory care are diverse and 
multifactorial. After adjusting for confounding variables, unemployment, distance 
from patient home to the clinic, living with HIV and being very ill during TB therapy 
remained significantly associated with a poor TB treatment outcome. 
Conclusions 
Although determinants of poor tuberculosis treatment outcomes in patients receiving 
six-month ambulatory care are diverse and multifactorial, poor tuberculosis treatment 
outcomes are significantly associated with identifiable factors independent of the 
health system. Rigorous intervention strategies should prioritize at least these five 
major risk factors. 
Recommendations 
The TB control programme should go beyond the health systems issues to include 
inter-sectoral collaboration to address socio-economic and other non-health system 
barriers to adherence to TB treatment. Further research is recommended in this field. 
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1 CHAPTER 1: INTRODUCTION 
1.1.1 Introduction 
Tuberculosis (TB) has received heightened attention in the past two decades owing 
to its dramatic resurgence as a major public health threat in many low-income 
countries. South Africa experiences one of the worst TB epidemics in the world. The 
World Health Organization (WHO) ranked South Africa fourth among 22 severely 
affected TB countries in the world in2008 (Stevens, 2008). 
The above finding is confirmed in the Management Sciences for Health (2004) 
Annual Report which states that South Africa continues to endure one of the worst 
TB epidemics in the world. Factors such as poverty, the Human Immunodeficiency 
Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) and attendant poor 
health infrastructure contributes to the high disease burden of TB and accentuates 
the low levels of cure achieved. Rural areas feature among the most severely 
afflicted (Management Sciences for Health, 2004).Such a finding is confirmed when 
the numerous challenges to access health care in rural areas are accounted for and 
taken into consideration. 
1.1.2 Background 
1.1.2.1 Overview of Tuberculosis in South Africa 
The resurgence of pulmonary tuberculosis in South Africa, a development that is 
further exacerbated by the HIV and AIDS epidemic now poses as a major challenge 
to the relevance, appropriateness, and effectiveness of those current TB 
management programmes being implemented. It is thus essential that these TB 
programmes need to be re-evaluated, especially in relation to their applicability in 
rural areas (Dodor, 2004). 
Nair et al. (2010) supports the contention that the observed rapid escalation of TB in 
sub-Saharan Africa   reflects the increase in the prevalence of HIV infection in this 
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region. Approximately two million deaths from TB are recorded annually in sub-
Saharan Africa (Nair et al., 2010). 
The burden of TB exerted upon the nation’s health services is overwhelming. 
Despite South Africa’s investment in TB control, progress toward reaching the 
programme objective has remained frustratingly slow and treatment success remains 
low compared with other African countries (USAID, 2006). 
“The incidence of detected tuberculosis has tracked trends in the prevalence of HIV 
since 1994. Although the incidence of new cases of smear positive pulmonary TB 
has not increased as sharply, this is mainly due to the high rate of smear negative 
TB and late detection of TB, especially among newly infected people living with HIV, 
(meaning that people often present first with TB complications other than lung 
infection “ ( Harrison, 2009). 
KwaZulu-Natal (KZN) province records the highest number of TB cases in the 
country (Cullinan 2004).In 2002, 36% of those diagnosed with TB were cured. Two 
years later, there was an improvement with a figure of 49% being achieved; a 
statistic that still ranks far below the WHO target of curing 85% of cases (Cullinan, 
2004). Currently, the TB cure rate in KZN is a mere 42% (Monticelli, 2008). 
At least two million of 9.4 million KZN residents living mostly in rural areas and 
informal settlements continue to lack adequate health care in the most populous 
province of South Africa. The combined impact of epidemics such as HIV and AIDS 
and TB frequently require labour-intensive methods of monitoring and combating for 
any success to be achieved. In addition, the socio-economic context wherein these 
diseases occur further inhibits any discernible progress in their control being 
achieved (Cullinan, 2004). 
Umgungundlovu Health District was declared a “TB Crisis Emergency Area" by the 
National Health Department due to the high incidence of the disease in 2006. The 
aforementioned region constitutes the district impacted by the second highest 
burden of TB in the province after Ethekwini Health District (National Department of 
Health 2006). 
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In uMgungundlovu only 35% of TB cases where cured in 2005. Currently the figure 
stands at 58%, a statistic, which remains below the specified 85% target (DHIS, 
2010). The low proportion of TB patients currently being cured in Umgungundlovu 
Health District and recorded in recent history makes essential an in-depth 
investigation to establish the patient-related factors that contribute to the attainment 
of such undeniably inadequate TB treatment outcomes in the course of combating 
this scourge. 
1.1.2.2  Overview of the Research Setting. 
Umgungundlovu Health District is the second largest health district in KZN province 
with a population of 980 000 to 1 million. It has seven local municipalities. The 
majority of the population in Umgungundlovu Health District is African (83%) followed 
by Asian (9%), White (6%) and Coloured (2%). Females comprise 53% of the 
population (Tang, 2008). 
 
Figure 1: Map of Umgungundlovu Health District in 2006 District. 
Source: Department of Local Government and Traditional Affairs, 2006). 
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The map shows the distribution of seven local municipalities in Umgungundlovu 
Health District. In this study, data was disaggregated per municipality. 
Table 1: Distribution of Population per Local Municipality in Umgungundlovu 
Health District in 2006. 
Municipality Population  % Population 
uMsunduzi 568606 59 
UMshwathi 93052 10 
uMngeni 76354 8 
Mkhambathini 69503 7 
Richmond 63602 7 
Mooi Mpofana 53435 8 
Impendle 31757 8 
Source: Department of Local Government and Traditional Affairs, 2006. 
Over half of the population in Umgungundlovu Health District lives in Umsunduzi 
local municipality hence most of the study sites for this research were located in this 
municipality. The other local municipalities combined comprised nearly the same 
size of population. The number of households is estimated to be between 240 000 to 
260 000. About 48% of the households (115 500) live in poverty (Umgungundlovu 
Municipality, 2006). 
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Figure 2: Population Pyramid of KwaZulu-Natal Province in 2001 
Source: Annual Report Department of Health KZN 2002 
The age-sex distribution in UMgungundlovu Health District is similar to that depicted 
in the population pyramid of KZN, which is typical of a developing or low income 
country. The target population for this study was adults between 18 and 70 years of 
age. 
The budget allocation in 209/10 financial year for Umgungundlovu Health District 
was approximately R1.6 billion, an amount required to cater for 8 hospitals and 42 
clinics (District Health Expenditure Review, 2010). 
1.1.3 Statement of the Problem 
New adult TB patients on the six month first line TB treatment regimen have poor 
treatment outcomes, a factor which impacts adversely on the proportion of TB cases 
being cured in Umgungundlovu Health District. 
1.1.4 Research Questions 
a. Why is the proportion of TB cases completing treatment low in new patients 
receiving TB treatment for six months in Umgungundlovu Health District? 
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b. What are the non-health system related barriers to patient adherence to TB 
treatment in this area?  
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1.1.5 Purpose of the Research 
The purpose of the study was to investigate non-health system related factors that 
lead to poor TB treatment outcomes in Umgungundlovu Health District in 2010. 
1.1.6 Specific Objectives of the Research 
The specific objectives of the study were: 
1) To identify those non-health system factors that contribute to poor treatment 
outcomes in TB patients; 
 To describe the socio-demographic characteristics of these patients; 
 To assess patients’ knowledge of and attitudes towards TB and TB 
treatment; and  
2) To determine the extent of support received by patients on TB treatment;  
1.1.7 Assumption Underlying the Study 
Non-health system factors contribute to successful or unsuccessful treatment 
outcomes in patients on ambulatory TB treatment, independently of the quality of the 
TB management programme. 
This study will provide service providers and health planners with information that will 
assist in the re-design and improvement of the prevailing six-month ambulatory TB 
management services. It will further serve to allocate resources efficiently and 
equitably. It will also generate other useful research topics. 
1.1.8 Operational Definitions Used in the Study 
New case: 
A patient who has never had treatment for TB or who has taken anti-tuberculosis 
drugs for less than four weeks (WHO, 2003). 
 
Treatment Outcome: 
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Treatment outcomes include bacteriological cure: patients with a positive smear or 
culture before treatment and negative bacteriological results at the end of TB 
therapy. It includes endpoints such as cure, treatment completion, treatment failure, 
default and interruption (WHO, 2003). 
Bacteriological Cure: 
Such a phenomenon concerns patients with a positive smear or culture before 
treatment and negative bacteriological results at the end of their therapy (WHO, 
2003). 
Treatment Completion: 
Patients who complete treatment without bacteriological proof of cure or failure 
(WHO, 2003). 
Treatment Defaulter: 
The World Health Organization defines a TB treatment defaulter as a patient whose 
treatment was interrupted for two consecutive months or more (WHO, 2003). 
Treatment Interruption: 
A patient who interrupts treatment for two weeks or more, and returns to the health 
service with smear-positive sputum (sometimes smear negative but still with active 
TB, as judged on clinical and radiological assessment) (WHO, 2003). 
Treatment Failure: 
Patients who fail to achieve bacteriological conversion within five months after 
commencing treatment, which become smear or culture positive again during 
treatment after previous conversion, or who are identified with multi drug-resistant 
TB (WHO, 2003). 
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Adherence: 
The extent to which a person’s behaviour relating to the taking of medication, 
following a certain diet and/or success in executing lifestyle changes corresponds 
with agreed recommendations from a health care provider (WHO, 2003). 
Multidrug Resistant Tuberculosis (MDR-TB) 
It is defined as a specific form of TB that is resistant to the two most powerful first 
line anti TB antibiotic drugs, namely, isoniazid (INH) and rifampicin. MDRTB is a 
laboratory diagnosis of resistance of the Mycobacterium tuberculosis to INH and 
rifampicin (WHO, 2006). 
1.1.9 Organisation of the Report 
This dissertation is divided into six chapters.  
Chapter one provides an overview of TB treatment and cure in South Africa and in 
the Umgungundlovu Health District with special reference being devoted to non-
health system related factors that contribute to successful or unsuccessful TB 
treatment outcomes. This chapter outlines the research setting, research questions, 
main objectives and purpose of the study. This chapter also provides definitions of 
concepts used in this research and report. 
Chapter two outlines the body of knowledge related to TB treatment outcomes and 
highlights the particular risk factors associated with poor TB treatment outcomes. 
Information is derived from empirical research reported in the literature.  
Chapter three describes the methods used in this research study. The study design, 
study population, data sources, sampling methods, variables and statistical analysis 
applied in this study are further explored in this chapter. The reliability and validity of 
the study and handling of bias and limitations are also described. 
Chapter four focuses on the results of the research study. The overall study 
population concerns the cases that yielded poor TB treatment outcomes due to non-
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adherence to TB treatment compared to controls that had successful outcomes. Risk 
factors associated with low TB cure are determined. 
Chapter five outlines the findings of the study and discusses these results in relation 
to previous studies and importance of these results for South Africa. 
Chapter six provides recommendations and conclusions based on the results of the 
study. 
1.1.10 Summary 
TB remains a major contributor to the burden of disease profile in South Africa and 
poor TB treatment outcomes continue to undermine all the efforts to achieve a cure 
of 85% of new TB cases, the target as set by WHO. There are numerous reasons for 
this and they include many non-health system related factors. 
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2 CHAPTER 2: LITERATURE REVIEW 
                       2.1 Introduction 
The current TB control programme has not been able to achieve an annual 85% cure 
rate in Umgungundlovu Health District in KZN province. The proportion of TB cases 
cured per annum has been as low as 29% in the past, and it is currently at 58% per 
annum. Such a figure is typical of many low income countries for new cases 
receiving ambulatory care, instead of hospitalization. The recommended treatment 
protocol for newly diagnosed ambulant TB cases involves six months of TB 
treatment. 
There are many who barriers to successful TB treatment outcomes and many of 
these are non-health system factors. This is supported by Atkins (2011) who states 
that a recent systematic review indicated structural factors, patient-related factors, 
the social context and health service related factors as important factors influencing 
treatment adherence and successful TB treatment outcomes. 
In this literature review the contribution of non-health system related factors 
described in the literature was assessed. This study assessed a number of these 
factors and their interrelatedness, thus contributing to a holistic picture of the 
problem.     
2.2   Purpose of Literature Review 
The purpose of the literature review was to establish the current extent of knowledge 
and awareness regarding non-health system factors that contribute to TB treatment 
outcomes, in order to draw inferences from empirical research. 
2.3 Scope of Literature Review 
Literature assessing factors related to poor TB treatment outcomes in new adult 
patients receiving six-month TB treatment were reviewed. The purpose thereof is to 
determine non-health system related risk factors associated with poor treatment 
outcomes. 
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2.3.1 Sources of Literature Reviewed 
The PubMed database was searched for studies pertaining to risk factors related to 
TB treatment outcomes between 1990 and 2011 in new adult patients on six-months 
of ambulant TB treatment. The following search terms were used to access citations 
related to risk factors: “TB treatment outcomes”, “factors associated with non-
adherence to TB treatment”, “effectiveness of DOT support”, “TB and HIV”. Library 
sources were also used to retrieve information on what is already known about the 
topic. It was also undertaken to identify the most appropriate theoretical framework 
to support the basis for this study. 
2.3.2 Literature Reviewed 
2.3.2.1 Tuberculosis Diagnosis and Treatment 
According to the Health Systems Trust (2008), the annual cure rate for new smear 
positive patients is regarded as the key indicator to assess a TB programme in a 
high-burden country. South Africa is working towards achieving the accepted WHO 
target of curing 85% of new smear positive TB cases. 
The process of TB diagnosis includes the following procedure: the patient presenting 
with both TB signs and symptoms is examined at a primary health care clinic and 
asked to supply a sputum sample on two consecutive days. These samples are 
forwarded to a laboratory and the results usually become available in less than 48 
hours. Only one of the above needs to record a positive result to confirm TB 
infection. (Department of Health, 2001). 
If the smear result is indeed positive, the patient will receive counselling and be 
advised on the inherent benefits of participation in the TB control programme. If both 
sputum samples are positive, TB treatment is given immediately. Furthermore, an X-
ray may also be taken, but the sputum tests may be enough to confirm the diagnosis 
(Department of Health, 2001). 
According Schaaf et al. (2009), TB can only successfully be cured if the full course of 
treatment, encompassing as much as six months duration of TB therapy is 
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completed. They further state that interruption of treatment is likely to enhance the 
development of multi-drug resistance, creating further complications in treating the 
disease, and can indeed be fatal. 
The classic presentation of TB is characterized by several weeks extending to a 
period of months of chronic cough, weight loss, fatigue, fevers, night sweats and 
haemoptysis. “Fever is a classically diurnal with an afebrile period early in the 
morning and a gradual rising temperature throughout the day, and culminating in a 
fever peak in the afternoon or evening. Nighttime defervescence is often 
accompanied by diaphoresis leading to drenching night sweats” (Schaaf et al., 
2009). 
“Physical examination is usually non-specific. Classic findings are pallor, cachexia, 
tachycardia and post-tussive crackles over the affected lung Treatment occurs in two 
phases “(Schaaf et al., 2009).The intensive phase involves the provision of four 
different drugs in tablet form for five days a week, for a period of two months. To 
facilitate the process of swallowing, the new combination drug Rifafour has been 
introduced (rifampicin, isoniazid, ethambutol and pyrazinamide) (Schaaf et al., 2009). 
The second phase is the continuation phase, where two drugs are supplied to the 
patient for five days a week for a period of four months. First-time TB patients must 
be treated for six months but for those on repeat treatment the duration of therapy is 
longer (Department of Health, 2011). 
Short course chemotherapy of six months duration, including rifampicin, at least 
provided in the intensive phase, can achieve a cure rate of 97 to 99%, and a relapse 
in less than 6%. 
Vasankari et al. (2007) recognized that early diagnosis of TB and then providing 
effective treatment constitutes the key elements involved in the reduction of 
transmission of infection and the final achievement of the goal of the elimination of 
TB. They emphasize that treatment outcome monitoring forms a core part of 
surveillance necessary to succeed in tuberculosis elimination. 
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TB drugs like any other medication have side effects, which can be very severe, and 
may cause patients to default treatment. Nausea was identified as one of the serious 
side effects of TB treatment that requires emergency attention (Solis, 2011). 
Schoenstadt (2006) states that occasionally, the medication used to treat 
tuberculosis may cause side effects. Some side effects cause minor problems; 
others are much more serious. The latter author states that serious side effects from 
TB medication may include, but are not are limited to lack of appetite, and symptoms 
of nausea and vomiting. In the study conducted by Elbireer et al. (2011) the side 
effects of treatment (OR 5.5; 95% CI: 2.3–13.6), was highlighted as a factor 
contributing to treatment default. 
In another study conducted by Munro et al. (2007), it was highlighted that complex 
regimens with potentially severe side effects cause non- adherence and poor TB 
treatment outcomes. This is further supported by Awofeso (2006) who asserts that 
anti-tuberculosis medication side effects were also found to be significantly 
associated with defaulting. 
2.3.2.2 Tuberculosis Treatment Outcome 
There is a consensus among authors that TB treatment outcomes include being 
cured, completion of treatment, treatment failure, default or death of the patient. In a 
study conducted on factors determining the outcome of treatment of adult smear-
positive tuberculosis cases in Gambia in 1994 and 1995, data was analysed on 1357 
patients and treatment outcome was recorded as the following: cured, completed 
treatment, failed, defaulted or died (Lienhardt et al., 1998). 
In another retrospective study that investigated factors associated with poor 
treatment outcome in the Southern Region of Ethiopia from 2002 to 2007 a sample 
of 6547 patients was categorized as having successful (cured or completed) or poor 
treatment outcome (failed treatment, defaulted or died) (Munoz-Sellart et al., 2010). 
Findings by JhaUm et al. (2006) findings were that amongst the large number of re-
treatment patients in India, default occurs early and often. Atkins (2011) argues that 
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adherence to TB treatment is a complex issue and it is closely connected with larger 
societal and historical forces. He draws a conclusion that adherence is therefore 
related to social inequalities and their impact on health and health care. 
Extensive research has been conducted on TB treatment outcomes. However, most 
studies have focused on health systems issues. Unfortunately, very little attention 
has been devoted to non-health system related factors contributing to treatment 
outcomes, yet there are three groups of non-health system constraints in the 
management of TB. These include: patient related factors, which concern the 
inability to access health services, a disadvantage which is likely to increase 
treatment interruption; lack of household income, lack of money for food and 
transport; and perceived social stigma. Other factors include contextual factors and 
health system factors (Naidoo, 2006). 
This is supported by Amuha et al. (2009) who state that non-adherence to treatment 
is a problem in tuberculosis management, similar to that applicable to other long-
term illnesses. They argue that a number of factors associated with non-adherence 
have been cited in the literature. These include health system, condition-related, 
patient-related, socioeconomic and therapy-related factors. 
The key to an effective TB control programme involves ensuring adherence to 
therapy. Adherence increases the likelihood of successful TB treatment outcomes 
including cure and reduces the risk of drug resistance, and is determined by a 
multiplicity of both internal and external factors (Wilkinson, 1997). 
2.3.2.3 Tuberculosis Treatment Outcome, Sex Age and Socio- Economic 
Status 
Authors have different views about the sex of the patient and treatment outcome. A 
prospective study conducted in England found that the risk factors for poor treatment 
outcome included being a male (Ditah et al., 2006). Whereas a retrospective study 
conducted in South Africa, found that the proportion of women (64%) who did not 
adhere to TB therapy was higher than for men (36%) (Mashimbye, 2009). Another 
South African based retrospective study showed that successful treatment outcomes 
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were significantly associated with male patients (Odour, 2006). Findings of a case-
control study conducted by Jhaum et al. (2006) in Indian in 2006 revealed that 
defaulters were more likely to have been male (OR 1.4; 95% CI: 1.2-1.7) Findings of 
another retrospective study, which reviewed TB patient records in Effia-Nkwanta 
Regional Hospital in Ghana in 2001, revealed that default from treatment was also 
significantly associated with the male gender (Dodor, 2004). 
In yet another study, multivariate analysis showed that the males were a predictor of 
a negative treatment outcome, after controlling for other significant socio-
demographic and health related variables. (Bashour et al., 2003).The findings of the 
study by Dooley et al. (2011) state that male sex, and substance use, appeared to 
be the principal risk factors for default. 
Another interesting finding of a study conducted in Yemen, concerned the fact that 
the role of male relatives positively influences treatment outcomes for female 
patients (Date et al., 2005). Such a fact highlights the complex role which a specific 
variable such as sex could of itself, form the framework for further research. The 
results of the study by Gupta et al. (2011) highlighted that PTB was significantly 
more common in male patients and unemployed people. 
Age does not seem to affect TB treatment outcomes. Findings of a retrospective 
study conducted on adults infected with TB in the United States between 1993 and 
2008, involving 250 784 participants, revealed that older patients who  were on TB 
therapy, had similar treatment outcomes  to those of younger adult  TB patients 
(Pratt et al., 2011). Age had no bearing on the treatment outcome.  I 
In a case-control study on new smear-positive pulmonary TB patients conducted by 
Pakasi et al. (2009) the prevalence of malnutrition and being unemployed were very 
high among TB cases. Socio-economic status also affects a person's access to 
effective healthcare in Ireland (Luddy, 2007). Socio-economic status would have a 
negative impact on the TB treatment outcomes, as those who are poor have less 
chances to adhere to TB therapy because of out of pocket expenses to cover 
transport and food. 
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Findings of a cohort study of 727 new TB cases between 2004 and 2009 conducted 
in Morocco revealed that a low income level remained significantly associated with 
treatment failure TB (OR 3.2; 95% CI: 1.1-9.3) (Tachfouti et al., 2011). 
Findings of a retrospective study conducted in Zambia in 2001 on 202 adult patients 
with pulmonary TB demonstrated that existing financial constraints and additional 
unrecognized patient costs, including special food expenditure, and travel distances 
served as barriers to a successful TB treatment outcome (Needham et al., 2004). 
A study conducted by Ogboi et al. (2010) revealed that most of the patients 
presenting with tuberculosis are in the economic productive age with unemployment 
and low literacy level being potent risk factors for tuberculosis. 
In a case-control study on new smear-positive pulmonary TB patients findings 
showed that the prevalence of both malnutrition and being unemployed ranked very 
high among TB cases (Bumburidi et al., 2006). 
Findings in another study highlighted homelessness, migration, alcohol and drug 
abuse, previous incarceration, unemployment,  and urban residence as risk factors 
that lead to poor treatment outcomes (Greene, 2004).The findings of the study by 
Muniyandi et al. (2008) also highlighted an association between TB and poverty, in 
terms of income, standard of living, house type and social class. 
There is yet further evidence to support the notion that the patient’s perspective, 
including socio-economic status and cultural environment, is an important 
consideration affecting the success of tuberculosis control programmes. Barriers to 
the completion of long-term treatment regimens include socioeconomic status, the 
health system and the condition itself (Garner et al., 2007). 
This is further supported by Hargreaves et al. (2011) who state that TB cases 
continue to cluster among disadvantaged groups such as the poor and the hungry. 
They further state that National TB incidence rates appear more closely correlated 
with social and economic determinants such as the human development index, 
access to water and sanitation (Hargreaves et al., 2011). 
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A similar observation was made by Cosgrove (2007) who demonstrated that poverty 
has an important influence on health and despite continuing economic growth, 
poverty and health inequalities persist. Needham et al. (2003) state that within poor 
resource settings, patients face financial constraints specifically related to travel 
distances and transportation costs, which create a significant burden on patients. 
Findings of a study conducted in South Africa also highlighted that deteriorating 
socio-economic conditions among already vulnerable populations is an important 
barrier to effective TB control (Weyer et al., 2007). Day et al. (2009) refer to the 
accompanying social environment which includes housing conditions, and rural 
versus urban settings. They state that deprivation is, however, concentrated in 
specific areas within the country and is correlated with ill health. Poverty is reported 
as a contributor to non- adherence to TB treatment (Day et al., 2007). 
Sachdeva (2011) argues that it is not clear as to what extent these differences result 
from biological factors and socio-cultural contexts. The literature, however, suggests 
that an overemphasis of cultural difference without further exploration of other social 
dimensions of health care delivery can obscure a practical understanding of relevant 
factors related to treatment outcomes. These include the hidden costs of treatment, 
poor access to care, ethnic discrimination, and prior poor treatment furnished by the 
health system. 
This argument is strengthened by a further study on adherence to tuberculosis 
treatment conducted in 2002 in India. Here, the argument is postulated that the 
reasons for default stem primarily from a poor correlation between patient and 
programme needs and priorities, and from characteristics of the disease and its 
treatment (Jaiswal et al., 2003). 
2.3.2.4 Tuberculosis Treatment Outcome and Level of Education 
A meta-analysis of studies identified illiteracy as a confounding variable associated 
with treatment outcomes (Munro et al., 2007). It can be asserted that lack of 
education does not hinder patients from receiving both a TB diagnosis and 
treatment. However, the traditional perceptions of illness may cause a longer 
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diagnostic delay among illiterate patients, as patients may perceive such illness as 
being of supernatural causation. 
Cheng et al.(2005) showed that lack of education and distance from home to a 
township health centre were significantly associated with delay in seeking care from 
service providers. This is further demonstrated by a prospective cohort study 
conducted in South Africa, which found that illiterate patients were more likely to 
interrupt treatment (Mashimbye, 2009). 
2.3.2.5 Risky Social Behaviours: Alcohol, Smoking and Drug Abuse and Non-
adherence to Tuberculosis Treatment 
Findings of a four year retrospective study that was conducted in Switzerland based 
on a computerised database and a review of medical records for 252 patients, 
revealed that alcohol abuse (OR 21; 95% CI: 2-288) and smoking were associated 
with unsatisfactory outcomes, and was also significantly associated with cavitatory 
pulmonary TB (Kherad et al., 2009). 
Findings of a cross sectional study conducted on 153 268 TB cases from 1997 until 
2006 in the United States showed that there was a significant association between 
drug and alcohol abuse and treatment failure (Oeltmann et al., 2009).A retrospective 
study conducted in Kasturba Hospital in South India also highlights smoking and 
alcoholism as risk factors for poor TB treatment outcomes (Gupta et al., 2011). 
The study by Dujaili et al. (2007) further reaffirms that tobacco smoking is a predictor 
of poor TB treatment outcomes. The findings of the study by Kherad et al. (2009) 
confirm that smoking appears as a possible risk factor. 
According to Gelmanova et al. (2007) in a multivariate model, substance abuse was 
identified as the only factor that was strongly associated with non-adherence with an 
odds ratio of 15 (95% CI: 4–70). 
This is further supported by Creswell’s (2011) findings that alcohol and injection drug 
use were the only independent risk factors for non-adherence and default that we 
identified. These findings echo those of numerous previous studies that found 
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substance abuse to be the single major factor associated most strongly with non-
compliance with TB regimens and resulting poor TB treatment outcomes. 
Dodor (2004) states that despite the clear need for new approaches to this problem, 
and to date there has been relatively little research on those treatment options for 
patients with chronic infectious diseases and who practise concomitant substance 
misuse. 
2.3.2.6 Tuberculosis and HIV and AIDS 
The HIV epidemic has significantly increased the incidence of TB, in high prevalence 
and poor resource settings. “The concomitant epidemics of HIV and tuberculosis 
present a major public health problem in South Africa” (Abdool Karim et al., 2007). 
Findings of a meta-analysis conducted in 2006, which focused specifically on long-
term adherence to TB treatment, revealed that TB and HIV present a particular 
challenge to adherence. Both are chronic infectious diseases that mainly affect the 
most vulnerable populations in terms of their being disadvantaged and the fact that 
they involve complex treatment regimens (Munro et al., 2007). 
A retrospective study conducted in KwaZulu-Natal, showed a high uptake of HIV 
testing for TB patients. The study reported HIV testing uptake on a monthly basis. 
More than 80%  knew their HIV status (Wallrauch et al., 2010).However in another 
cross-sectional study conducted in the Free State Province only a third (32%) of TB 
patients had not undertaken HIV testing,  due to a combination of individual related 
factors, and also health systems limitations including non-offer of HIV testing (Kigozi 
et al., 2011). 
This outcome is echoed by the findings of the study conducted in Spain by Diez 
Ruiz-Navarro et al. (2005) who showed that the outcome for tuberculosis treatment 
greatly deteriorates in those living with HIV. Abdool Karim et al. (2004) argue that 
with the high rates of HIV co-infection (60%), the impact of HIV on outcomes of these 
patients is substantial. 
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This was also confirmed by Schaaf et al. (2009) who found that in southern African 
countries, where HIV prevalence is highest, more than half of new TB cases are 
living with HIV. In South Africa this was corroborated in a study that showed that HIV 
associated TB- co-infection was approximately 55% in 2002 (Gasa, 2009). 
Heysell et al. (2010) contend that those living with HIV (PLHIV) are prone to 
malabsorption and are at higher risk for low drug levels.This is echoed by Nahid et 
al. (2007) who state that PLHIV- were significantly more likely to develop drug 
resistance (4.2% in HIV-infected versus 0.5% in HIV-uninfected) to rifampicin, and to 
experience adverse reactions to TB treatment regimens. 
Findings of a retrospective study of 700 patients with TB, conducted in San 
Francisco from 1990 to 2001, revealed that TB relapses were found to be 
significantly higher in people living with HIV on a standard six-month therapy 
compared to those HIV-uninfected patients. According to the authors, the current TB 
treatment guidelines do not distinguish between those infected with HIV and those 
who are uninfected, in terms of the length of treatment. They argue that a standard 
six-month therapy may be insufficient to prevent relapse TB associated HIV (Nahid 
et al., 2007). 
Results of a South African based article review Naidoo et al. (2007) also showed that 
treatment interruption rates are much higher in patients living with HIV who have TB 
than HIV negative patients. This is likely due to the burden of co-infection. 
Sebastino et al. (2009) state that the immune recovery associated with antiretroviral 
therapy (ART) results in dramatic clinical benefits. The still believed that using ART 
might not be appropriate during the first weeks of anti-TB therapy in HIV-infected 
patients due to immune reconstitution problems (Sebastino et al., 2009). 
Initiation of ART during anti-TB treatment can lead to immune reconstitution disease 
(IRD) manifested as worsening of symptoms and signs or appearance of new TB 
lesions. The majority of cases have been reported to occur within the first two 
months of ART (Schaaf et al. 2009). 
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On the contrary Lonnroth et al. (2009) state that ART reduces risk of poor TB 
treatment outcomes in patients living with HIV. This is further supported by Nahid 
(2007) who found that the use of ART during TB treatment was associated with a 
faster Mycobacterium tuberculosis negative culture conversion, and an improved 
survival. 
2.3.2.7 Tuberculosis Treatment Outcome and Directly Observed Therapy 
Treatment success achieved in the 2005 Directly Observed Treatment (DOT) cohort 
yielded over two million patients scoring 84.7% success on average; close to the 
85% target. Global targets for TB control refer to treatment success for new smear-
positive cases treated under DOT (WHO, 2006). 
In a study conducted by Dudley et al. (2011) in South Africa it is reported that 
community health worker support contributed to better TB control programme 
performance than an approach based exclusively on health facilities. 
Findings of a study evaluating directly observed therapy for tuberculosis in KZN in 
2009 revealed that districts that had received high DOT coverage had recorded 
better cure rates (Ntshanga et al., 2009).The findings of a controlled trial on DOT, 
conducted in Thailand on 836 patients diagnosed in 1998, were in agreement with 
above findings (Kamolratanakul et al., 1999). 
According to a WHO report treatment success rates tend to be lower in patients 
without DOT support and those on self-administered therapy (SAT) than those for 
new cases treated under DOT (WHO 2008).This is echoed by Jasmer et al. (2004) 
who reported  thatlevels of cure was significantly higher in those treated by DOT 
compared those on self-administered therapy.  (98% vs. 89%, p < 0.002). 
Conversely the findings of the study conducted in South Africa by Zwarenstein 
(1998) suggest that treatment for tuberculosis was more successful among self-
supervised patients (60% of patients) than among those on DOT (54% of patients). 
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Garner et al. (2007) argues that models that involve either family or community 
members provide an opportunity to tackle existing  social and family barriers 
contributing to poor TB treatment outcomes,  including encouraging family members 
to complete treatment. There was also a strong association between the frequency 
of DOT support and TB treatment outcome. 
Hargreaves et al. (2011) confirm that DOT has significantly reduced TB morbidity 
and mortality, and remains one of the most cost-effective public health interventions 
ever implemented, although findings of a study conducted in Nepal indicated that 
community DOT and family-member DOT achieved success rates of 85% and 89% 
respectively (Newell et al., 2006). 
A cluster randomised trial conducted in Senegal found that decentralization of 
treatment and patient choice of DOT supporter led to improvement in patient 
outcomes compared to the usual TB control procedures (Thiam et al., 2007). A 
South African based study also found that DOT was 2.8 times cheaper to deliver 
than the conventional treatment (Floyd et al., 1997). 
2.3.2.8 Multidrug Resistant Tuberculosis (MDRTB) 
A South African based case-control study has investigated both favourable and 
unfavourable outcomes, in order to compare determine which factors, lead to better 
adherence to MDR-TB treatment. The study conducted by Moodley et al. (2011) in 
KZN highlighted the fact that 20% of patients had cultures positive for MDRTB. 
Sturm (2010) states that, the number of MDR per 100 new cases is 14.8 in 
Umgungundlovu Health District. 
Results of a systematic review indicate that TB treatment outcomes were 
substantially worse in the presence of initial drug resistance (Lew et al., 2008). 
Consensus among authors is that the low levels of treatment success, has resulted 
in an increasing MDR-TB burden. The appearance and growth of resistance to anti-
tuberculosis drugs threatens the success of the tuberculosis DOT programme and 
the ART distribution programme (Abdool- Karim et al., 2009). 
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A retrospective 10 year review of patients diagnosed with MDR-TB conducted in 
Victoria found that the number of patients diagnosed with MDR-TB increased, and if 
sustained, the increase will have important implications for public health policy and 
planning (Lavender et al., 2009). Brust et al. (2011), in another study, revealed that 
80% of MDR-TB patients were HIV co-infected. Another study conducted by Kliiman 
et al. (2009) highlighted that one of the risk factors for poor treatment outcome in 
MDRTB was HIV infection. 
2.3.2.9 Knowledge, Beliefs and Practices of TB Patients 
The literature shows that patients’ knowledge of TB has been assessed previously, 
including knowledge of signs and symptoms of TB, mode of transmission and TB 
drugs. Findings of a cross-sectional study conducted in Vietnam revealed that sex; 
occupation, economic status, education and sources of information were significantly 
associated with level of TB knowledge (Hoa et al., 2009). 
Previous studies have also investigated use of contemporary and alternative 
medicine during TB therapy. Findings of qualitative research conducted in Zambia 
highlighted that patients often consider the advice of respected individuals and use 
of herbal self-treatment of their symptoms. TB patients paid the equivalent of 10% of 
their monthly income for consultation with a traditional healer, while others tried self-
medication with drugs from a local pharmacy (Needham et al., 2003). 
In sub-Saharan Africa, traditional healers outnumber medically qualified doctors 
eighty-to-one. It also remains a region in which most people turn first to traditional 
healers on becoming ill. Traditional healers also usually provide immediate 
treatment, whereas clinics may have lengthy waiting lists and eligibility criteria tests 
(Hsiao et al., 2003).  
A quarter of the patients in KwaZulu-Natal consulted a traditional healer sometime 
during their illness and once they knew they had TB. Sixteen per cent of the patients 
went to a traditional healer as their first choice of care. Of those who went to a 
traditional healer, 72% were male (Loveday et al., 2007). 
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2.3.2.10 Conceptual Framework 
Bandura’s Cognitive Social Learning Theoretical framework was used to explain 
adherence behavior in this study. Munro et al., (2007) argue that theories play a role 
in the design of behavioural change interventions by promoting an understanding of 
adherence behaviour. 
Bandura (1986) argues that human behaviour is learned observationally through a 
process of modeling. One forms an idea as to the means whereby new behaviours 
are developed, derived from observing other actors. Furthermore, such coded 
information serves as a guide for action (Bandura, 1986). 
According to Bandura (1986), observational learning incorporates four components: 
attention, retention, motor and motivational processes that help to understand why 
individuals imitate socially desirable behaviour. 
He further suggests that other factors involved herein are the influence of social 
groups, and the structural arrangement of human interactions. Retention processes 
deal with the ability to remember the observed model, as well as mentally organizing 
and rehearsing the particular behaviour concerned. Motor reproduction comes 
through trial and error, observation of behaviour or skill (Bandura, 1986). 
The latter author states that motivational processes explain why people usually enact 
those behaviours that seem to be effective tools for other people. There exists a 
greater inclination to adopt modeled behaviour if it results in outcomes which are 
valued, rather than if it results in unrewarding or punishing effects (Bandura, 1986). 
Bandura argues that people operate cognitively on their social experiences. These 
conditions then influence behaviour and development. The influences of behaviour, 
namely individual, cognitive, and environmental factors determines how people both 
interact and learn from each other. Human behaviour is explained as a dynamic and 
correlated interaction between the person and the environment (Bandura, 1986).  
 







Personal Factors      Environmental Factors 
(Cognitive, affective, and biological events) 
Figure 3: Conceptual model 
Source: Boeree & George, 2008 
One of the main tenets of Bandura’s theory is that personality is an interaction 
between three factors: the environment, behaviour, and a person’s psychological 
processes. 
According to this particular theory, people are definitely not driven by inner forces nor 
are they automatically shaped and controlled by external stimuli. Such an argument  
is very relevant in relation to the investgation into contributory factors leading to TB 
treatment outcomes. 
 As a result  the proposition  demonstrates that internal motivation to adhere to 
treatment is not in itself a sufficient factor to produce a cure. Internal motivation in 
some patients may be sufficient. However, in others, it may well be overshadowed, 
or even eroded, by external circumstances and social contexts. It is on the basis of 
this theory that the study attempted to investigate those multiple factors that 
influence TB treament outcomes.  
The above notion is also supported by Benson’s Behavioural model as cited by 
Bandura (1986). The assumption of this model is that human behaviour is a product 
of multiple dynamic factors that develop synergistically in combination with genetic, 
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psychological and environmental vulnerabilities. Predisposing factors include 
personality and coping style. 
2.3.2.11 Summary 
This chapter presented the findings of previous studies that have relevance and 
significance to the study that has been conducted. The common trend was that most 
of the studies were retrospective observational studies. This is similar to the 
research design used in this study and has sound scientific basis. It remains 
appropriate to highlight factors associated with poor TB treatment outcome. Similar 
non-health system related factors have been identified as affecting TB treatment 
outcomes, regardless of the country wherein the study was conducted.  
Although the emphasis on the majority of the studies was on health systems 
performance in relation to TB treatment outcomes, some of the studies highlighted 
non-health system factors were identified in this particular study. These include 
significant association between low socio-economic status and non- adherence to 
TB treatment. Other factors include smoking, alcohol, and drug abuse. Other 
significant factors identified were HIV infection, MDR-TB and DOT support.  
The limitation of these studies is the tendency that exists of investigating different 
factors in isolation, for example examining factors such as drug abuse, culture or 
poverty, independently of other variables. Such research might answer the question 
as to why some patients exposed to a similar social milieu can still be cured, whilst 
others are not. Further analysis will also be facilitated in understanding how these 
contributory variables interplay to result in either a favourable or an unfavourable 
outcome. 
The study also draws from the theoretical framework as it has used Bandura’s 
cognitive, social learning theoretical model to assess patient related factors that 
contribute to TB treatment outcome. Relevant terms were defined in this chapter. 
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3 CHAPTER 3: METHODS 
3.1 Introduction 
The resurgence of TB combined with low levels of cure in Umgungundlovu Health 
District warrants an in-depth investigation into non-health system related factors that 
contribute to poor TB treatment outcomes. This study explored the following relevant 
issues: demographic characteristics, socio-economic status, harmful social 
behaviours, immunologic and pathological characteristics, DOT support programme, 
and the health seeking behaviour characteristics of new adult TB patients who have 
been exposed to six-month TB treatment.  
In this chapter, the type of research undertaken and the study design are outlined. 
The chapter further describes the study population, sampling strategy, data sources, 
data management, statistical methods and analysis, as well as bias and limitations of 
the study design and findings. 
3.2 Type of Research 
This study was an epidemiological research study. 
3.2.1 Study Design 
An observational analytical study using a case-control design was used. This study 
design was appropriate for the primary objectives as it provided comprehensive data 
on the cases that had poor TB treatment outcomes and who had not completed six 
months of therapy in the six-month period, since their period was prolonged beyond 
six months because they had either interrupted or defaulted treatment, and returned 
to the health system for further management with or without smear positive result 
upon their return. According to WHO (2003) the endpoints of treatment outcome 
include cure, treatment completion, treatment failure, interruption or default. These 
cases that interrupted or defaulted TB treatment were judged to be having active TB 
clinically and by radiological examination. These were thereafter compared with 
those controls that had indeed had successful completed six months of treatment in 
the prescribed time.  
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The study quantified the extent of non-health system- related factors affecting poor 
TB treatment outcomes by investigating are factors that could contribute to this. The 
study will provide service providers and planners with information that will help them 
design TB control programmes and allocate resources efficiently (Katzenellenbogen 
et al., 2002). 
3.2.2 Study Setting 
The study was conducted in the primary health care facilities in Umgungundlovu 
Health District in KwaZulu-Natal. 
3.2.3 Target Population 
The results of this study could be generalized to new adult TB patients who received 
six-month TB treatment in other districts in South Africa, which are similar to the 
Umgungundlovu Health District in KwaZulu-Natal. 
3.2.4 Study Population 
The study population constituted the entire aggregate of TB patients both those who 
had completed their ambulatory TB therapy within the prescribed 6-month period. 
The accessible population for the study comprised those TB patients who were 
attending the local health facilities and were conforming to designated criteria as 
participants of the study.  
Inclusion criteria: 
The study included adult patients (18 years and above) who were diagnosed with 
pulmonary tuberculosis (PTB) in a health facility and, therefore, would have had the 
opportunity to complete a six-month course of TB treatment on an ambulatory basis. 
Patients who had completed six months of treatment within the time period 
constituted the controls. 
The cases were those who had started treatment but had either interrupted or 
defaulted therapy and failed to complete six months of therapy within the time period 
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and were re-introduced back to the health system and therefore were unable to finish 
TB treatment within six months. Those who interrupted treatment had not taken TB 
treatment between two weeks to one month, and those who defaulted had not taken 
TB treatment for two consecutive months or more’   Cases and controls were 
obtained from the local TB registers in the clinics of the same district population of 
UMgungundlovu Health District during the study period. 
Exclusion criteria: 
Hospitalized TB patients were excluded from the study. Although this was a captive 
population, hospitalized patients were not representative of the reference population 
due to a number of factors.  Hospitalized patients may not necessarily be residing in 
Umgungundlovu Health District because of the occurrence of a cross boundary flow 
of patients having been referred from EThekwini, Thukela, UMzinyathi and ILembe 
Districts. Many hospitalized patients may be more ill than those who are on 
ambulatory treatment, and the administration of TB treatment in a hospital is very 
different from what pertains in a clinic. Therefore, factors relating to completing 
therapy timeously would be different in hospitals, from those in primary health care 
settings. 
3.2.5 Sampling 
3.2.6 Sampling Method 
Mulistage sampling was conducted.  
1.The first stage of sampling involved the selection of 15 out of a total of 42 clinics. 
Clinics were categorized as urban, semi-urban and rural. Urban clinics are those 
situated in a settlement that is legally proclaimed within a municipal or local authority 
boundary as urban, and they have formal, informal and other facilities built according 
to municipal by-laws. Semi-urban clinics are situated in an area that is not part of a 
legally proclaimed urban area, but adjoins it. Rural clinics are part of the area that 
falls outside of legally proclaimed urban areas, and include commercial farms, small 
settlements and rural villages (Census 96). 
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A proportional random sample of each category of clinic was selected so that there 
were a total of 15 clinics. This ensured a balance of urban, semi-urban and rural 
clinics. The study sites randomly selected were: Ashdown Clinic, Caluza Clinic, East 
Boom Community Health Center (CHC), Imbalenhle CHC, Gomane Clinic, 
Mafakathini Clinic, Mpumuza Clinic, Ndaleni Clinic, Ntembeni Clinic, Nxamalala 
Clinic, Pata Clinic, Richmond Clinic, Sondelani Clinic, Songonzima Clinic and 
Taylor’s Clinic. Selecting 63% of the clinics (15) from a total of 42 clinics would allow 
for an adequate sample size required for the study, and it was based on the 
estimated population that is served by these clinics in Umgungundlovu Health 
District. 
2. The second stage of sampling involved a probability proportional to size random 
sampling of TB patients and who were new smear positive cases, within those 
selected clinics. An unmatched control on a one to one basis was selected from 
each clinic register. The selection was done consecutively. Cases were selected first 
and the next immediate patient who completed treatment functioned as the control. 
The next person listed on the TB register who had not completed six months of 
therapy was selected as the next case until the required sample population was 
available. 
3.2.7 Size of Sample 
A biostatistician was consulted before undertaking the study to give guidance as to 
sample size, and the power of the study. There was no existing data to calculate 
sample size. However, based on the assumptions and established trends that 
Umgungundlovu Health District has the second highest number of TB patients, and 
the fact that the proportion of cases cured is low. There were 3913 TB patients on 
the TB registers at the beginning of this study in the 15 selected clinics. The highest 
proportion was in bigger clinics that serve a larger population. The study size was set 
at 300 cases and 300 controls to control for at least 10 confounding factors. 
The sample size calculations were based on a cure of 35% in Umgungundlovu 
Health District, and a minimum detectable odds ratio of 1.5. The power of the study 
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was 80% and the confidence interval 95% to ensure statistical and clinical 
significance.  
The study thus comprised 600 participants; 300 cases, and 300 controls randomly 
selected from the facilities’ TB registers. Cases involved those patients with new 
smear positive pulmonary tuberculosis commenced on the full six-month course of 
treatment, but who interrupted or defaulted their TB treatment and who failed to 
complete TB treatment in the prescribed 6-month treatment period. These patients 
were identified as cases when they presented back to the health system usually as a 
result of being tracked by the TB tracing teams. These patients would have had a 
chance to complete TB therapy in six months, however they had interrupted or 
defaulted which meant that had to re-enter the system, and thus prolong therapy 
beyond six months period. 
The controls were identified at the point where they had completed six months of 
therapy within the time period without interrupting and defaulting and were sputum 
smear-negative at the end of the six-month treatment period.  
3.2.8 Data Sources 
3.2.9 Measurement Instruments/ Data Collection Techniques 
The measurement instrument used was a structured questionnaire administered by 
12 trained fieldworkers. The questionnaire covered a broad spectrum of areas and 
these included the demographics of the participants, their socio-economic status, 
risky behaviours like alcohol, smoking and drug abuse, DOT support, HIV status, 
physical condition during treatment as well as knowledge, attitudes and practices of 
TB and TB treatment. The questions were structured to determine non-health system 
factors associated with treatment outcome, which was either completion of treatment 
within six months, with a smear negative result or interruption or default resulting to 
failure to complete treatment within six months, and the reasons thereof.  
Fieldworkers were trained by the researcher. 
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3.2.10 Data Abstraction 
Patients themselves were the primary sources of data in this study. Data was 
obtained from them at the time that they completed the six months period when 
treatment was completed or should have been completed. However, clinic based TB 
registers were used to select patient samples as well as patient records, which were 
used to confirm susceptibility profiles and treatment outcomes.  
Twelve field workers collected data by means of a structured questionnaire. 
Fieldworkers were trained to ask the questions in a uniform manner throughout, thus 
minimizing inter- and intra-investigator variation. Questions were administered in 
both English and isiZulu to cater for those participants who preferred to be asked in 
isiZulu. Interviews were conducted in the 15 selected clinic sites. Cases were 
presenting back to the health system on a continuous basis through the Defaulter 
Tracing Teams, and some came back on their own as their condition was getting 
worse. Data collection took place over a period of ten months. 
Field workers were trained intensively to adhere to ethical procedure, especially 
relating to questions of anonymity and confidentiality, as well as concerning the 
rights of participants, data collection and handling. Supervision and periodic checks 
were performed by the principal investigator. 
3.2.11 Data Handling 
A quality check at the site was done by field workers with the assistance of 
operational managers of the study sites and errors were corrected on the document 
by the researcher. 
Questionnaires with recorded responses from participants were checked for 
completeness. Data was recorded onto a data form, accompanied by the 
corresponding identification numbers for cases and controls. Quantitative data was 
first aggregated manually to screen for completeness of data and for identification of 
outliers. The hard copies of the questionnaires containing patients’ responses and all 
data sheets were locked in a safe place to ensure confidentiality. 
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Data was entered electronically from the questionnaire onto a database (Dataset 1) 
Errors were corrected. Data was cleaned for missing data, inconsistency, and 
typographic error. Entered data was then summarize and prepared for analysis 
(Dataset 2) 
Dataset 1 and Dataset 2 were validated by the data capturer and the researcher 
through the checking of source documents to ensure correct entry. Electronic data 
was safeguarded by using only one computer and the password was only known by 
the Principal Investigator. 
3.2.12 Variables 
Exposure variables fell into two categories as follows: 
Numerical Variables (Quantitative variables) 
 Discrete numerical variables. – Taxi fare 
 Continuous numerical variables – Income 
 Binary variables-  Sex, marital status, employment status 
 Ordinal variables, which follow a natural order - educational level completed: no 
education, / grades completed / Tertiary education etc. 
Examples of variables that were measured included access to a health facility in 
terms of distance and financial access, access to TB therapy in terms of distance to 
the clinic, DOT support, level of knowledge of signs and symptoms and 
understanding of TB in terms of the information that is made available to the 
community through various  sources and forms of media, mode of transmission, 
knowledge of drugs, adherence (obtained both from self-report of patients and TB 
register), socio economic status, and the perception of quality of care received from 
health care providers, including experiences of patients in a health facility during 
treatment. 
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3.2.13  Validity of Data Sources 
3.2.13.1 Internal Validity 
The study was piloted at Edendale Hospital Gateway Clinic in Umgungundlovu 
Health District on a sample of 10 TB patients to ensure that what was being asked 
made sense 1(Face validity). Content validity was also ensured by asking similar 
questions in different ways at different places in the questionnaire. The variables 
tested were constructed in a simple language. The questionnaire was also provided 
in isiZulu.2 
3.2.14 Bias and Limitations 
3.2.14.1 Selection Bias 
This was unlikely to be a problem in this study as clinics were randomly selected to 
be representative of all the clinics in the health district. Cases and controls were 
selected consecutively at the selected clinics. The controls were selected from the 
same population that produced the cases. 
3.2.14.2 Information Bias 
The interviewer, being aware of the identity of cases and controls, could have 
unconsciously probed further among cases, seeking a positive association. The 
interviewers were trained to avoid probing, and if not avoidable to be consistent in 
asking questions to all participants throughout the interview process. 
                                            
1The pilot study enabled the researcher to modify the questionnaire to ensure 
content validity 
2  The majority of patients who participated in the study were Africans, hence the 
importance of having a questionnaire in their own language. 
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Misclassification was minimized through the proper training of interviewers. Data was 
carefully checked for inaccuracies. Differential and non-differential misclassifications 
were reduced throughout all stages of the research. During sampling participants 
were categorized correctly into cases and controls. Completed questionnaires were 
numbered from one to 300 for each group and labeled as either cases or controls. 
Data entries on the spreadsheet were done according to the two groups, namely 
cases and controls, and data analysis was done to compare the two groups thus 
minimizing measurement error. Data presentation on tables clearly distinguished the 
two groups. To prevent these sources of bias, extensive training of data collectors 
was undertaken, and biostatistician was consulted. 
3.2.14.3 Recall Bias 
To avoid selective recall among both cases and controls, prompts were used during 
interviews to stimulate accurate recall. Prompts were only used in the aspect of 
knowledge of participants in relation to signs and symptoms of TB, mode of 
transmission and knowledge of TB drugs. Patients who had received treatment 
within only a few months prior to the study were selected. 
3.2.15 Social Desirability Bias 
The study might have contained information bias as study participants might have 
furnished information that would impress the researcher, and not the reality which 
prevails in real situations. Examples hereof involved responses concerning alcohol 
intake, substance abuse, smoking and the use of alternative medicine. To reduce 
this bias, respondents were assured of anonymity, and advised that their responses 
were most useful if they reflected the true situation. 
3.2.16 External Generalisability 
External validity refers to the extent to which the results of the study can be 
generalized to and across populations. The size of the sample was adequate to 
ensure an 80% power, and a 95% confidence limit. 
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Results of this study are generalisable to the TB patient population in rural areas of 
South Africa, because the study was conducted in public sector clinics, which is how 
TB care is delivered to most TB patients in South Africa. 
3.2.17 Confounding Factors 
The fact that each independent variable may act as a confounder when assessing 
the effect of each independent variable on the dependent variable on univariate and 
bivariate analysis was considered. These confounders included sex, age, 
geographical area of residence, distance from home to the clinic, level of education, 
socio-economic status, HIV status, MDRTB, smoking, drug and alcohol abuse, DOT 
support and use of alternative medicine during TB treatment. Adjustment for 
confounding variables was achieved by using multivariate analysis to control for 
confounding effects. 
3.2.18 Statistical Considerations 
3.2.19 Descriptive Methods 
Data were abstracted to Microsoft Access 2007 database, and thereafter imported 
into Microsoft Excel and SPSS version (PASW Statistics 18) for cleaning of data 
summarizing the data into basic frequency measures. 
3.2.20 Analytical Methods 
Univariate, bivariate and multivariate analyses were conducted. Univariate analysis 
of socio-demographic variables, as well as of adherence and other outcomes were 
done in order to describe the data. Bivariate analyses were performed to test 
associations between TB outcomes and socio-demographic variables, and other 
independent variables using Chi square.  
The significance level was set at p <0.05. Odds ratios and 95% confidence intervals 
were calculated. A non- parametric (Mann- Whitney) test was used to analyse 
quantitative variables, which were not normally distributed as relates to distance from 
home to clinic and cost of a taxi fare between home and the clinic. 
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Multivariate analysis was performed to test the confounding effect of variables of 
interest, using cured/not cured of TB as the dependent variable. Standard logistic 
regression model incorporating an indicator variable in the model corresponding to 
each case- control set was used (Kirkwood, 2005). 
Binary logistic regression analysis was performed in order to control for confounding 
while assessing the individual effects of the independent variables. For example, 
data was stratified by degree of urbanization (rural, semi- rural, urban), 
unemployed/employed, distance from home to clinic to calculate responses to TB 
treatment per each stratum of urbanization. 
Those variables which were significantly associated with case/control status on 
bivariate analysis were entered into the model as independent variables. Backward 
stepwise selection was used to arrive at a final model. 
Data was coded, captured and analysed using SPSS (PASW Statistics 18) under the 
guidance of the Statistician. Finally, the Database was then analysed, and the results 
presented in appropriate tables and figures. 
3.2.21 Ethics 
The research protocol was approved by the University of KwaZulu Natal Biomedical 
Research Ethics Committee (BF 112/09) (Appendix A) before this study was 
conducted. 
3.2.22 Permissions 
Permission was sought from the Head of the Department of Health, KZN in writing to 
conduct research in the Umgungundlovu Health District primary health facilities and 
was accordingly granted. Permission to undertake the study in Umgungundlovu 
Health District primary health care facilities was also sought from the District 
Manager, Mrs. NM Zuma-Mkhonza. 
Written informed consent was obtained from the participants, in a language with 
which the participants felt comfortable using. Participants were assured that 
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withdrawal or refusal to participate in the study was not going to exert a negative 
impact upon them or compromise their health care. 
Respondents were assured of confidentiality and anonymity. No respondent names, 
identity, or patient card numbers were collected in this study, and questionnaires 
were not made available to anyone, except the investigator and data capturers. 
Completed questionnaires were locked in a safe place to ensure confidentiality. 
Original questionnaires will be destroyed after a period of two years. 
Results of this study will be communicated to the respondents by posting them on 
the clinic walls and in information brochures that will be distributed to the study sites. 
A copy of the report will be submitted to the Umgungundlovu Health District 
Manager. A copy of the dissertation will be made available to the KZN Provincial 
Department of Health. A report of this study will be submitted for publication to a 
peer review journal. 
3.2.23 Pilot Study 
A pilot study was conducted at Edendale Hospital Gateway Clinic in Umgungundlovu 
Health District. It was a small-scale study using a sample of five patients for each 
group, (five cases and five controls). The group was similar to the target population 
to be studied. The purpose of the pilot study was to test the validity and reliability of 
the measurement instruments. Words, phrases, sentences or questions that were 
not clearly understood were recorded by the researcher. Refinements were made to 
the questionnaire based on the findings of the pilot study. Data from the pilot study 
were not included in the data analysis. 
3.2.24 Summary 
This epidemiological study used an observational retrospective case-control design 
to measure the non-health system related risk factors associated with TB treatment 
outcomes. The purpose of the study was to investigate non-health system related 
factors that contribute to poor TB treatment outcomes in Umgungundlovu Health 
District. In this chapter the study population, study sampling methods, data sources, 
data processing and analysis, biases and limitations were described. The study was 
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conducted on new TB adult cases that had an opportunity to complete a standard 6-
month TB treatment course. The data was collected from 15 randomly selected 
primary health care clinics in Umgungundlovu Health District .The study comprised 
of 300 cases and 300 controls. The primary source of data was patients themselves, 
data was collected by means of interview based on a structured questionnaire, and 
secondary sources were TB Registers and Patient-held TB Carrier Cards. Data was 
analysed on SPSS programme, and the results are presented in the next chapter.  
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4 CHAPTER 4: RESULTS 
4.1.1 Introduction 
The purpose of this retrospective case-control study was to measure non-health 
system -related risk factors that contribute to poor TB outcomes due to patients 
interrupting their therapy and not completing their treatment in the prescribed six-
month period in the Umgungundlovu Health District in KwaZulu-Natal. The study 
population comprised of 600 new cases diagnosed with pulmonary TB (PTB) that 
were initiated on six month of TB treatment on ambulatory care and would have had 
a chance to complete treatment within six months. The cases were those who 
interrupted or defaulted treatment, but returned to the health system and thus not 
being able to complete TB therapy within six months. These were compared to 
controls that completed TB therapy within six months and were cured after six 
months of TB treatment on ambulatory care, based on a smear negative result. In 
this chapter the contribution of non-health system factors to TB treatment outcome 
are presented. According to WHO (2003) the end points of treatment outcome 
include cure, treatment completion, treatment failure, interruption and default. Socio-
economic, demographic, setting and other non-health system characteristics of 
cases and controls were summarised in Tables 2 to 12.  
4.1.2  Demographics  
The proportion of male cases who had poor outcomes (n=161, 54%), in the sample 
was slightly higher than that of female cases (who completed their therapy in six 
months and were cured) (n=139, 46%). There was however no statistically significant 
difference in sex among the cases and controls. There were 139 female cases (46%) 
and 138 female controls (46%), 161 male cases (54%) and 162 male controls (54%). 
Sex was not a risk factor for poor completion of TB treatment within six months in 
this study (p=0.935) (Table 2). 
Two thirds of cases (n=180, 60%) were in the 18 to 30 year old age group. There 
was a higher proportion of younger patients who had poor outcomes. A one sample 
Chi-square test showed that this was statistically significant (p<0.05). 
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There was no significant difference in age between cases and controls (p=0.138) 
overall. The categories of age group occur in the cases and controls with equal 
probabilities. However, the proportion of participants between age group 18 to 30 
years in both cases and controls was much higher compared to other age groups 
(Table 2). 
Two thirds of cases (n=188, 63%) and controls (207, 65%) were single 
(p<0.005).There was no significant difference in relationship status between cases 
and controls (p=0.884).The various categories of relationship status occurred with 
equal probabilities in both groups. Relationship status was not a risk factor for poor 
TB treatment completion in the prescribed time period. 
A higher proportion of cases (n=54, 18%) had no education compared to controls 
(n=14, 5%). This was statistically significant (p<0.05). 
Only 27 cases (9%) had Matric compared to 105 (35%) of the controls. Only three 
cases (1%) had tertiary qualification compared to 42 controls (14%). A lower level of 
education is a risk factor for not completing TB therapy at within 6 months (p<0.05) 
(Table 2). 
4.1.3 Socio-economics 
The majority of cases (n=274, 91%) were unemployed compared to 89 (30%) 
controls There was a significant association between unemployment status and non-
adherence to TB therapy. A low proportion of cases (n=15, 3%) reported being 
employed, whereas (n=190, 63%) controls reported being employed (p<0.05) (Table 
3). 
The majority of cases (n=274, 91%) reported that they were earning less than R1000 
per month compared to controls (n=90, 30%). The only source of income for cases 
was from temporary disability grants (social pensions). There was a statistical 
difference between cases and controls in terms of lower income bracket for cases. 
(p<0.05). (Table 3) The majority of controls earned between R4000 and R5000 
(n=77, 26%) compared to cases (n=7, 2%). Only (n=4, 1%) of cases reported 
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earnings above R5000, whereas controls were more likely to earn within this income 
bracket (n=80, 27%) There was a statistical difference between cases and controls in 
terms of higher income bracket for controls. (p<0.05) (Table 3). 
The majority of cases (n=232, 85%) reported going to bed hungry at least three 
times per week compared to controls (n=77, 26%) and more cases than controls 
(n=42,14%) reported going to bed without any food three times a month compared to 
controls (n=6, 2%). The majority of controls (n=217, 72%) did not report any lack of 
food during TB therapy compared to 26 (9%) of cases.  
There was a statistically significant association between lack of food not completing 
TB therapy within the six-month period (p<0.05). 
4.1.4 Residential Area, Housing, Water Source and Sanitation 
The majority of cases (n=179, 60%) lived in a more rural area compared to controls 
(n=106, 35%). The majority of controls (n=185, 62%) lived in a township compared to 
cases who lived in the same setting (n=113, 37.6%).There was a significant 
difference between cases in terms of area of residence. Living in a rural area was 
significantly associated with non–completion of TB therapy (p<0.05) (Table 4). 
Less than half (n=127, 42%) of cases reported that they live in brick houses 
compared to controls (n=240, 80%) whereas the majority of cases (n=160, 53%) 
lived in mud houses compared to controls (n=49, 16%).There was a significant 
difference between cases controls with regard to type of housing they lived in 
(p<0.05).  
The majority of cases (n=242, 83%) drew water from a community tap compared to 
controls (n=176, 60%). A low proportion of cases (n= 49, 17%) had access to piped 
water compared to controls (n=117, 40%).There was a significant difference between 
adherers and non-adherers to prescribed therapy with regard to their source of water 
(p < 0.05) (Table 4). 
The majority of cases (n=294, 98%) reported using pit toilets for sanitation in their 
homes compared to 252 controls (84%) and only 6 (2%) of the cases used flushed 
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toilets in their homes compared to 47 controls (16%).This result was statistically 
significant (p<0.05).  
4.1.5 Alcohol, Drug Use and Smoking among Adult TB patients 
More of the cases (n=86, 38%) reported that they drank alcohol compared to 66 
controls (24%), which showed a statistically significant difference (p=0.037). Alcohol 
is a risk factor for not completing TB therapy within the six-month period. 
The majority of cases (n= 74, 29%) reported smoking compared to 66 controls (18%) 
(p=0.018). Smoking is a risk factor for cases, as they did not complete continuous six 
months of TB therapy, by either interrupting or defaulting treatment. 
More cases (n=39, 13%) reported using illicit drugs compared to only one of the 
controls (0.3%). Reported illicit drug usage is a risk factor for cases, as they did not 
complete continuous six months of TB therapy, by either interrupting or defaulting 
treatment. 
4.1.6 Directly Observed Therapy for Tuberculosis 
The majority of both cases (n= 247, 82%) and controls (n= 246, 82%) had equal 
access to DOT support (p=0.524).  
The majority of cases (n=200, 81%) had DOT supporters allocated by a health 
worker. Only 47, a low proportion of cases (19%) had DOT supporters of their own 
choice (p<0.05).  
Most cases (n=159, 64%) had a Community Health Worker (CHW) as a DOT 
supporter compared to 26 controls (11%), whereas the majority of controls (n=189, 
77%) had family members providing DOT support, and lower proportion (n=60, 24%) 
for cases supported by family members. This was statistically significant (p<0.05) 
There was no significant difference in the proportion of cases and controls who 
received DOT support from a friend, partner or pastor (p=0.500). 
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The frequency of DOT support for the majority of controls (n=216, 90%) was daily, 
whereas 193 (80%) of cases had daily DOT support. A higher proportion of cases 
(n=33, 14%) had DOT support on a weekly basis compared to controls (n=17, 7%). 
A high proportion of cases (n=14, 6%) had only occasional DOT support compared 
to controls (n=7, 3%).Cases had far less daily contact with DOT supporters 
compared to controls who had contact with DOT support more frequently and 
regularly, which is statistically significant as a risk factor for not completing TB 
therapy within the six-month period either by interrupting or defaulting treatment, 
(p<0.05) in this study. 
There was equal proportion of patients who administered TB medication themselves 
(SAT) in both cases (n=54, 18% and controls (n=55, 18%).There was no statistically 
significant difference in self-administered (SAT) TB treatment between cases and 
controls (p=0.500) (Table 6). 
4.1.7 HIV and AIDS  
A statistically significant proportion of cases (n=132, 44%) reported that they were 
living with HIV compared to 74 controls (25%) (p< 0.05). 
A higher proportion of cases living with HIV (n=39, 30%) were on ART compared to 
only nine (12%) of the 74 controls.More cases were on antiretroviral drugs than 
controls (p<0.05). 
4.1.8 Severity of Illness of Adult TB Patients 
The majority of cases (n=297, 99%) remained AFB smear positive after two months 
of TB therapy. There was a highly statistically significant difference in smear 
conversion after two months on those taking regular TB treatment between cases 
and controls (p<0.05). 
The majority of the cases (n=297, 97%) had interrupted or defaulted treatment. Out 
of this total 236, (79%) interrupted their TB therapy for at least one month, while 60, 
(18%) defaulted TB therapy for two months and four (1%) defaulted TB therapy for 
three months. This is statistically significant (p<0.05). 
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The majority of cases (n=295, 98%) stated lack of money as the reason for their non-
adherence to TB therapy, and 186 (62%) of cases stated that both lack of money 
and ill health were reasons for non-adherence. Patients who defaulted TB therapy 
and remained smear positive after two months were tested for MDRTB as part of the 
standard TB management protocol. All the cases (n=300, 100%) were tested for 
MDRTB, and (14%) of those tested were found to be MDRTB positive (p<0.05) 
(Table 8).  
The most severe state of illness during TB therapy was observed and reported 
among cases. A high proportion of the cases (n=118, 39%) more often reported to 
be very ill during treatment than controls (n=41, 14%), as well as being fairly ill 
(n=180,60%) compared to controls (98, 33%).This was statistically significant as one 
of the risk factors for non-adherence to TB therapy (p<0.005).Just over half of the 
(n=161,54%) controls reported being reasonably well during TB therapy compared to 
only (n=2,0.6%) cases. 
Cases were also more likely to have side effects to TB therapy compared to controls. 
(n=178, 59%) cases had side effects due to their TB therapy compared to controls 
(n=40, 13%).Nausea was the commonest side effect (p<0.05). The majority of 
controls did not report any side effects to TB therapy (n=260, 87%), compared to 
(n=122, 41%) cases. 
Both 16 (5.5%) cases and 16 (5.5%) controls had equally reported other physical 
illnesses other than TB whilst on TB therapy. The most common conditions were 
hypertension, diabetes mellitus and arthritis (p=0.500) (Table 8). 
4.1.9 Other, Health Seeking Behaviour, Knowledge, Attitudes and Practices of 
Adult TB Patients 
More cases (n=63, 21%) reported using some form of alternative medicine whilst on 
TB therapy compared to controls (n=34, 11%). Controls were less likely to seek 
alternative medicine during the course of TB therapy. A report of having used an 
alternative practitioner was found to be a statistically significant risk factor not 
completing TB therapy within the six-month period (p<0.05). 
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The type of practitioner that was consulted by 42 cases (14%) was a traditional 
healer compared to 21 controls (7%) This was followed by a diviner (isangoma) 
which was consulted by cases (n=14, 5%) compared to controls (n=4, 1%) This was 
statistically significant (p<0.05) (Table 9).  
Cases were less likely to consult a homeopath (n=4, 1%) compared to 8 controls 
(2%) The result was however not statistically significant (p=0.014). Conversely cases 
were more likely to consult a faith healer (n=41, 14%) compared to controls (n=12, 
4%) This was however not statistically significant. (p= 0.191). Only (n=26, 9%) of 
cases who used alternative medicine reported that it was effective and only (n=21, 7) 
controls. Ten cases (3%) reported that alternative medicine relieved cough, 
compared to eight (2%) of the controls. Only (n=16, 5%) of cases reported that 
alternative medicine restored energy and only (12, 4%) of controls reported similar 
effect. This was statistically significant (p<0.05). 
Both cases and controls were less likely to report relief of night sweats from taking 
alternative medicine (n=5, 2%) cases and (n=7, 2%) as well as restoration of 
appetite respectively (n=1, 0.3%) and controls (n=2, 0.5) this was not statistically 
significant (p=0.500). 
On assessing knowledge levels, both 300 cases (100%) and 300 controls (100%) 
demonstrated adequate knowledge of at least four signs and symptoms of TB and 
mode of TB transmission without being prompted. There was no significant 
difference between cases and controls with regard to knowledge of signs and 
symptoms of TB as well as TB mode of transmission (p=0.500).  
Cases were less likely to know which TB drugs they were taking as only (n=15, 5%) 
of the 300 respondents knew the TB drugs they were taking without being prompted, 
whereas 285 (95%) of cases did not know the names of TB drugs even being 
prompted. This was statistically significant (p<0.05). Cases demonstrated poorer 
knowledge of TB medication that they were taking compared to adherers. 
Both cases (n=300,100%) and controls (n=300,100%) had reported that they 
received good care from the staff at the clinic from which they were collecting their 
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TB medication. There was no significant difference between cases and controls in 
terms of care received at the clinic (p=0.5) (Table 9). 
No stigmatisation against these TB sufferers was reported in the 300 cases (100%) 
and 300 controls (100%) (p=0.5). 
A slightly higher proportion of cases (n=100, 33%) reported that other family 
members staying with them were being treated for TB as well compared to controls 
(n= 87, 29%). However this was not statistically significant as a risk factor for non-
adherence (p=0.15). 
Continuous Variables 
Continuous variables were computed using Mann-Whitney test. This was followed by 
comparison of means 
4.1.10 Distance to Clinic, in Kilometres and Taxi fare in Rands 
The median range for distance travelled by the majority of cases to the clinic was 16 
km compared to a median of 4 km for controls. Cases were more likely to travel 
longer distances to the clinic compared to controls.There was a significant difference 
between cases and controls in terms of the distance travelled from home to the clinic 
(p<0.05).There was strong association between non-adherence to TB treatment and 
distance from home to clinic and the cost of transport from home to clinic (Table 10). 
The mean taxi fare was R14.00 for cases compared to R6.00 for controls from home 
to the clinic. Cases were more likely to spend more money on taxi fare due to the 
distance travelled compared to controls. This is a significant risk factor for not 
completing TB therapy within the six-month period (p<0.05). 
4.1.11 Number of people in the household and number of sleeping rooms 
Although the median number of sleeping rooms in the household was the same in 
cases and controls, the distribution was wider in the cases, meaning that cases 
tended to have more people in the house than controls.The majority of cases shared 
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their homes with a median of 18 people, compared to the median of eight people for 
controls. Both the number of people and the number of rooms were measured. This 
was statistically significant (p< 0.05). 
  
  50  
 
Table 2: Comparison of Sex, Age, Marital Status and Level of Education of Adult TB patients (Cases and Controls) in 
Umgungundlovu Health District, 2011. 




 P Value 
Sex Female 139(46.4%) 138 (46.0%)  p=0.935 
 Male 161(53.6%) 162 (54.0%)   
      
Age (years.) 18-30 180(60.0%) 179 (59.7%)  p=0.138 
 31- 40  66 (22.0%) 70 (23.3%)   
 41-50 24 (8.0% 26 (8.0%)   
 51-60 30 (10.0%) 25 (8.3%)   
      
Relationship Status Single 188(62.0%) 207 (69.0%)  p=0.884 
 Married 39 (13.9%) 34 (11.3%)   
 Divorced 9 (3.2%) 14 (4.6%)   
 Widowed 15 (5.0%) 15 (5.0%)   
 Living with partner 49 (17.5%) 30 (10.0%)   
      
Level of education  None 54 (20.0%) 14 (4.9%)  p<0.05 
(completed) ABET 18 (6.7%) 2 (0.6%)  p<0.05 
 Grade 1-5 67 (24.8%) 37 (12.3%)  p<0.05 
 Grade 6-9 131 (43.6%) 100 (33.3%)  p<0.05 
 Matric 27 (9%) 105 (35.2%)  p<0.05 
 Tertiary  3 (1.1%) 42 (14.2%)  p<0.05 
 
  51  
 
Table 3: Comparison of Employment Status, Income and Going to Bed without Food of Adult TB patients (Cases and 
Controls) in Umgungundlovu Health District, 2011. 





Employment Status Unemployed 274 (91.3%) 89 (29.6%)    p<0.05                
 Full Time 15 (5%) 190 (63.3%) p<0.05 
 Part Time 11 (3.6%) 21 (7.0%) p<0.05 
     
Income – Rands / Month <1000 274 (91.3%) 90 (30.0%) p<0.05           
 1000-1999 2 (0.6%) 7 (2.3%) p<0.05 
 2000-2999 5 (1.6%) 17(5.6%) p<0.05 
 3000-3999 8 (2.6%) 29 9.6%) p<0.05 
 4000-4999 7 (2.3%) 77 (25.6%) p<0.05  
 >=5000 4 (1.3%) 80 (26.6%)  
     







In a month Three times a 
month  
42 (14.0%) 6 (2.0%) p<0.05 
  
Not at all 26 (8.6%)                  217 (72.3%) 
p<0.05 
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Table 4: Comparison of Residential Area, Housing, Water Source and Sanitation of Adult TB patients (Cases and Controls) 
in Umgungundlovu Health District, 2011. 




 P Value 
Residential area 
Rural 179 (59.6%) 106 (35.3%)  p<0.05                
 
Township 113 (37.6%) 185(61.6%)  p<0.05 
 
Urban 7 (2.3% ) 9 (3%)   
   Out of 299 Out of 300  
      
Housing Brick house 127(42.3%) 240 (80.0%)  p<0.05                
 Mud house 160 (53.3%) 49 (16.3%)  p<0.05                
 Other 13 (4.3) 11(3.6)  p=0.500 
      
      
Water source Community tap 242 (83.1%) 176 (60%)  p<0.05                
 Piped water 49 (16.8%) 117 (39.9%)  p<0.05                
  Out of 291     Out of 293   
      
Sanitation Pit toilet 294 (98.0%) 252 (84.3%)  p<0.05 
 Flush toilet 6 (2.0%) 48 (16 %)  p<0.05 
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Table 5 Comparison of Alcohol, Smoking and Drug Use in Adult TB Patients (cases and controls) in Umgungundlovu 
Health District, 2011 




 P Value 
Drinking Alcohol  86 (37.7%) 66 (23.9%)   p=0.037 
  Out of 228 Out of 276   
Drug use  39 (14.9%) 1 (0.3%)  p<0.05 
  Out of 262    
Smoking  74 (29.1%) 52 (18.1%)  p=0.018 
  Out of 254 Out of 287   
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Table 6: Comparison of Directly Observed Therapy for Tuberculosis (Cases and Controls in Umgungundlovu Health 
District, 2011 




 P Value 
Access to DOT Support Yes 247 (82.3%) 246 (82%)        p=0.542 
      
Health Worker Choice  200 (80.9%) 30 (12.1%)  p<0.05 
     P<0.05 
Own Choice  47 (19.0%)  216 (87.8%)   
 




Out of 247 
 
159 (64.3%) 





     p<0.05 
 Family member 60 (24.2%) 189 (76.8%)          p<0.05 
 Friend 22 (8.9%) 26 (10.5%)  p=.5 
 Partner 3 (1.2%) 4 (1.6%)  p=.5 
 Pastor 3 (1.2%) 1 (0.4%)  P=.5 
  Out of 247 Out of 246   
Frequency of DOT Daily  193 (80.4%) 216 (90%)  p<0.05 
 Weekly    33 (13.7%) 17 (7.0%)  p<0.05 
 Occasional  14(5.8%) 7 (2.9%)     p<0.05 




 54(18%) 55 (18 3 %%)  p=0.500 
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Table 7: Comparison of HIV and AIDS among Adult TB patients (Cases and Controls) in Umgungundlovu Health District, 
2011. 




 P Value 
HIV positive Yes 132 (44%) 74 (24.6%)  p<0.05 
HIV + on ART Yes 39 (13%) 9 (3%)  p<0.05 
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Table 8: Comparison of Severity of Illness of Adult TB patients (Cases and Controls) in Umgungundlovu Health District, 
2011. 




 P Value 
Smear positive after two months  296(99%) 0(0%)  p<0.05 
      
Number of months interrupted or defaulted 1 Month 236 (78. 6%) 0 (0%)  p<0.05 
 2 Months 60 (18%) 0 (0%)  p<0.05 
 3 Months 4 (1.3%) 0 (0%)  p<0.05 
      
Reasons for defaulting No money 295 (98.3%) 0 (0%)    p<0.05 
 Ill health 186 (63%) 0 (0%)  p<0.05 
      
Tested for MDRTB  300 (100%) 0 (0%)  p<0.05 
      
MDRTB positive  42 (14%) 0 (0%)  p<0.05 
      
Very ill  118 (39.3%) 41 (13.6%)   p<0.05 
Fairly ill      180 (60%) 98 (32.6%)  p<0.05 
Reasonably well  2 (0.6%) 161(53.6%)   
      
TB treatment side effects  178 (59.3%) 40 (13.3%)  p<0.05 
Not at all  122(40.6%) 260(86.6%)   
      
Any other physical illness  16 (5.3%) 16 (5.3%)  p=0.500 
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Table 9: Comparison of Other, Health Seeking Behaviour, and Knowledge, Attitudes and Practices of Adult TB patients 
(Controls) in Umgungundlovu Health District, 2011. 




 P Value 
Used alternative medicine   
63 (21%) 21(7%) 
 p<0.05 
Practitioner consulted Traditional healer 
Diviner 
 42 (14%) 
14 (4.6%) 




 Homeopath 4 (1.3%) 8 (2.6%)  p=0.19 
 Faith healer 41 (13.6%) 12 (4%)  P<0.05 
Effectiveness of alternative 
medicine 
Restored energy 16 (5.3%) 12 (4%)   
 Treated night sweats 5 (1.6%) 7 (2.3%)  p=0.5 
 Restored appetite 1 (0.3%) 2 (0.6%)  p=0.5 
  6 9   
TB Knowledge:  4 signs & symptoms- 300 (100%) 300 (100%) 0.000 p=0.5 
 Prompted 















No Knowledge of TB 







             
 
p<0.05 
Other members treated     100(33.3%)  87 (29%)     P=0.15 
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Continuous Variables 
Continuous variables were computed using Mann-Whitney test. This was followed by 
comparison of means 
Distance from Home to the Clinic and Transport Cost 
 
Table 10: : Comparison of Distance to Clinic, in Kilometres and Taxi fare in 
Rands for Adult TB patients (Cases and Controls) in Umgungundlovu Health 
District, 2011. 





Distance from Clinic 
(median in km; range) 
 
Taxi fare to clinic 
(median in R, range) 
 
 16 (1-55) 
 
 
14 (6-40)                                            






Table 11: Comparison of Number of people in the household and number of 
sleeping rooms for Adult TB patients (Cases and Controls) in Umgungundlovu 
Health District, 2011. 




Median number of people in the 
household 
1.924 (1-18)                                                 1.574 (1-8)
(range) 
Median number of sleeping rooms in the 
household(range) 
1.074 (1-13)                     
 
 .826 (1-5) 
Number of sleeping rooms and number of people in the household 
The majority of cases share the sleeping rooms with a large number of people, 
median 18, whereas the median for controls is eight. 
Although the median number of people in the household is the same in cases and 
controls, the distribution is wider in the cases, meaning cases tend to had more 
people in the house than controls. This is statistically significant (p<0.05). 
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Multivariate Analysis Results: 
Methodology: 
Binary logistic regression analysis was performed in order to control for confounding 
while assessing the individual effects of the independent variables. Those variables, 
which were significantly associated with case/control status on bivariate analysis, 
were entered into the model as independent variables. Backward stepwise selection 
was used to arrive at a final model.  
Multivariate analysis was performed to test the confounding effect of variables of 
interest, using cured/not cured of TB as the dependent variable. Standard logistic 
regression model incorporating an indicator variable in the model corresponding to 
each case- control set was used .After 10 steps the variables remaining in the model 
were unemployment, distance from home to the clinic, living in a rural area, living 
with HIV and being very ill during TB therapy. 
Employment: 
After adjusting for confounding variables using logistic regression, being unemployed 
versus full time employment was16 times more likely in non-adherers sounded in 
the. Unemployment remained significantly associated with non-adherence to TB 
therapy in Umgungundlovu Health District (OR 16.0; 95% CI: 6.7 to 37.8; p<0.005). 
Distance from Clinics: 
After controlling for confounding variables, distance from home to the clinic 
increased by one km, and the odds of being a case increased 1.5 times. Distance 
from home to the clinic is significantly associated with non-adherence to TB therapy 
(OR 1.4; 95% CI: 1.3 to 1.6; p<0.005). 
Area: 
Those in rural areas were the most likely to be cases. Those in townships versus 
rural were (67.4%) less likely to be cases. After adjusting for confounding variables 
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living in a rural area remained significantly associated with non-adherence to TB 
therapy in Umgungundlovu Health District (OR 14.3; 95% CI: 1.1 to 18; p <0.0                                                               
05). 
HIV Status: 
After adjusting for confounding variables, TB patients who were living with HIV were 
2.3 times more likely to be cases. Living with HIV remained significantly associated 
with non-adherence to TB therapy in Umgungundlovu Health District (OR 2.3; 95% 
CI: 1.1 to 4.7; p<0.005). 
Severity of Illness: 
After controlling for confounding variables, TB patients who reported being very ill 
during treatment phase were 5 times more likely to be cases. Being very ill during TB 
therapy remained significantly associated with non-adherence to TB therapy (OR -
5.0; 95% CI: 2.1 to 11.9; p<0.005). 
Table 12: Multivariate Analysis 
Characteristics of 
Step 10 
Difference Significance           OR 95% Confidence 
Intervals 
Not employed vs. 
Employed 
2 .00 16.0 6.8-37.9 
Full time vs. part 
time 
 
1 .47 1.7 0.4-7.9 




1 .00 0.3 0.2-.663 
     
Township vs. 
Rural 
1             .00 14.3                  1.1 -18  




1 02 2.3 
1.1-4.7 
Very ill whilst on 
treatment 
1 .00  5.0 2.1- 11.9 
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Summary 
This chapter presented results that showed statistical significance on a number of 
variables that are associated with TB treatment outcomes. On univariate and 
bivariate analysis, cases were more likely to interrupt or default TB treatment due to 
factors like their male gender, low level of education, low income, living in a mud 
house and sharing the house with a large number of people. Other factors 
highlighted were lack of food, lack of money, ill health, less frequent contact with 
DOT support, use of alternative medicine, alcohol, smoking and drug abuse. 
Multivariate analysis highlighted unemployment, living in a rural area, long distance 
from home to clinic, HIV infection and being very ill during treatment as risk factors 
associated with poor TB treatment outcomes. 
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CHAPTER 5: DISCUSSION 
Introduction 
In chapter five, the significant patient -related factors to TB treatment outcomes are 
discussed. This study has generated a number of significant and interesting findings, 
which allow a holistic picture of the predicament of patients with regard to adherence 
to TB treatment to be arrived at in Umgungundlovu Health District in 2010. 
The aim of the study was to identify those patient-related factors, which contribute to 
successful or unsuccessful outcomes in patients who have had the opportunity to 
complete six months of TB treatment in Umgungundlovu Health District. 
The hypothesis was that patient-related factors contribute to non-adherence to TB 
therapy not completing TB therapy within the six-month period in patients receiving 
ambulatory TB treatment, independent of the quality of the TB management 
programme. The present study involved a case control study including 600 
participants: 300 cases and 300 controls. TB treatment constituted the exposure and 
the outcome which, was either interrupted, defaulted or cured. 
The present study has found that a failure to achieve an 85% TB cure rate per 
annum in Umgungundlovu Health District, in which the study was conducted, is due 
to multiple factors. A number of patient related factors have been found to contribute 
to non-adherence to TB treatment. The findings of this study considered possible 
biases and limitations in terms of the study design, method of data collection and 
results obtained. 
The format of the discussion is similar to the results and it is presented under the 
following 11 headings: 
Sex, Age, Marital Status and Level of Education; 
Employment Status, Income and Going to Bed without Food; 
Residential Area, Housing, Water Source and Sanitation; 
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Alcohol, Drug Use and Smoking; 
Directly Observed Treatment; 
HIV and AIDS; 
Severity of Illness; 
Other Health Seeking Behaviour, Knowledge, Attitudes and Practices; 
Distance to Clinic, in Kilometres and Taxi fare in Rands; 
Number of People in the Household and Number of Sleeping Rooms; and 
Major Risk Factors after controlling for confounders using logistic regression. 
Sex, Age, Marital Status and Level of Education 
The demographic characteristics of this study population differ from other 
observational studies. 
Sex 
This case- control study found that there was no statistically significant association 
between sex and adherence to TB therapy, although the proportion of male was 
slightly higher than that of female cases in Umgungundlovu Health District ().Sex on 
its own is not a contributory factor to not completing TB therapy within the six-month 
period. 
The results of this study corroborates the findings of a case control study conducted 
in China on 659 new smear positive TB cases in 2005 also revealed that being a 
male was not an independent risk factor associated with TB treatment 
default.(Xianqin et al., 2009). 
A similar finding was made in a-retrospective study conducted in Nigeria on 983 TB 
patients, which showed that there was no significant difference in default rate 
between male and female patients (15.3% versus 13.5%, p=0.432) (Amoran et al., 
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2011). Another retrospective review of records conducted in Nigeria also showed 
that there was no significant difference in default rate between male and female 
patients. Comparing the sex of compliant and non-compliant groups was not 
statistically significant (p>0.05) (Erhabor et al., 2000). Another retrospective study 
conducted in South Africa, found that the proportion of women (64%) who did not 
adhere to TB therapy was higher than for men (36%) (Mashimbye, 2009). Another 
South African based retrospective study showed that successful treatment outcomes 
were significantly associated with male patients (Odour, 2006). 
Other studies elsewhere do not support this finding. A retrospective study conducted 
in India showed that treatment success rates were higher in women (89 %) than 
those in men (87%) and fewer women dropped out of TB treatment than men (4% 
default rate for women and 6% default rate for men) (Sachdeva, 2011). Another 
retrospective study conducted in Ghana, which showed that default from treatment 
was significantly associated with the male sex (Dodor, 2004). A retrospective cohort 
study based in South Africa highlighted that women were more likely to complete 
treatment successfully (68%) compared to men (63%) (van der Walt et al., 
2002).This study found like other studies elsewhere found that sex was not a risk 
factor for non-adherence to TB therapy in Umgungundlovu Health District, although 
other studies had contrasting findings. This provides opportunity for further research. 
Age 
This study demonstrated an equal proportional distribution of age between controls 
and cases. There was no statistically significant difference in age groups between 
cases and controls in this study However it must be noted that half) of participants 
who participated in the study were between the age group of 18-30 in 
Umgungundlovu Health District. This is an indication of TB burden among young 
adults in Umgungundlovu Health District. The findings of this study corroborate the 
results of a retrospective study conducted in United States from 1993-2008, which 
showed that older adults and younger completed therapy in a timely manner and 
treatment outcomes were similar between the two groups ( Pratt et al., 2011). 
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The findings of this study are contrary to the findings of a retrospective study 
conducted in Ghana, which showed that patients in the 25-44 year age group and 
those put on the retreatment regimen demonstrate higher defaulter rates (Heysell et 
al., 2010). Age was not associated with non-adherence to TB therapy in this study. 
Level of education  
Controls o had higher educational standards, compared to cases, and therefore were 
more likely to adhere to TB treatment. This is statistically significant (p<0.05). The 
chances of patients with higher education to comply with six month TB therapy are 
higher due to the fact that they are more enlightened about the implications of not 
completing TB therapy within the six-month period. The majority of them would be 
having jobs, and it would be critical for them to complete treatment. There is 
significant association between low education level among cases and treatment 
default (p<0.05). Patients with low levels of education might not understand fully the 
implications of non-adherence to treatment. The majority of them would be 
unemployed, and travelling to a health facility to collect TB medication this puts an 
extra financial burden on them. 
The results of this study corroborate other observational studies. In a case-control 
study conducted in China low education level was one of the independent risk 
factors for non-cure (Xianqin et al., 2010). This result also correlates with the findings 
of a retrospective study which highlighted that successful treatment outcomes were 
significantly associated with those whose highest education levels were tertiary and 
secondary (Odour, 2006). 
In another retrospective study conducted in China on 190 new smear-positive TB 
patients, multivariate analysis using Cox Regression showed that lack of education 
was significantly associated with a delay in seeking care from service providers. 
(1.24; (5% CI 0.82-1.90) (Cheng et al., 2005).A retrospective record review 
conducted in Nigeria on 694 case records revealed a statistically significant 
association between low literacy level and TB (p<0.005) (Ogboi et al., 2010). Lack of 
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education and low level of education contributed significantly to non-adherence to TB 
therapy in this study. 
                   Socio-economics: Employment Status 
This study demonstrated that the proportion of unemployed cases was higher 
compared to controls. Unemployment was a significant risk factor for treatment 
default (p<0.05). Multivariate analysis using logical regression showed that 
unemployed patients were 16 times more likely to default treatment than employed 
patients in Umgungundlovu Health District. Unemployed patients are worse off as 
they lack basic resources for day-to-day survival. They have no means of transport 
to get around, and they are mostly likely to default long-term TB treatment because 
of poverty, as they cannot afford out of pocket expenses related to their health care. 
The findings of this study corroborate other observational studies elsewhere. 
Findings of a retrospective record review conducted in Nigeria on a 694 case records 
revealed that most of the patients presenting with tuberculosis are in the productive 
age with unemployment serving as potent risk factors for non- adherence to TB 
treatment in the study area (p < 0.05) (Ogboi et al., 2010). 
A cohort study conducted in Morocco on 727 new TB cases also showed significant 
association between low income and treatment failure (OR 3.3, 95% CI: 1.1-9.3 
(Dooley et al 2011). This finding also correlate to a retrospective study conducted in 
South Africa on 450 patients in 2006 which revealed that patients who were 
unemployed were more likely to be lost to follow up (Kharsany et al., 2006). 
Another retrospective cohort study conducted in South Africa on 400 participants 
demonstrated that unemployed people had 1.6 times higher risk of unsuccessful 
treatment outcome than employed people (p<0.05.The findings of this current study 
indicate that unemployment poses a burden on TB patients who have to be on six 
month therapy on the ambulatory basis. 
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                Income per Month 
This study revealed that the majority of cases () had no basic income and were 
dependent on temporary disability grants only. There was a significant association 
between lack of income and non-adherence to TB therapy (p<0.05). This is directly 
linked to unemployment. These patients cannot afford to meet the health care 
costs, due to other priorities, which include food and education for children. 
The results of this study are comparable to the results of a prospective descriptive 
study conducted in Thailand, which highlighted illness-related costs of (15%). of 
the total annual household income. This affects patients with income below the 
poverty line, (Kamolratanakul et al., 2009). 
In line with the findings of this study though slightly lower was the results of a 
cross-sectional study conducted in Tanzania which showed that (21%) of patients 
did not have a defined income (van den Boogaard, 2009). Another retrospective 
study conducted in Morocco on 727 patients highlighted that low income remained 
significantly associated with treatment failure (OR 3.3, 95%CI 1.1-9.3) (Tachfouti 
et al., 2011). 
In this study the challenge of poverty, a factor which links directly to lower levels of 
education, unemployment, low income, poor living conditions, the distance to a 
clinic, and out of pocket expenses is evident. These are factors predisposing to 
non-adherence. Patients who live below the poverty line and who rely only on 
social grants for their sustenance are more likely to default on treatment than 
those who fare in a higher socio-economic category. The majority of TB patients 
rely on the disability grant which is less than R1000 for their survival. These 
patients are less likely to afford out of pocket expenses for six months duration of 
ambulatory care. 
                     Going to Bed without Food 
This study showed that a high proportion of cases went to bed without food in most 
instances three times a week and on some occasions, less than three times a month 
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respectively in Umgungundlovu Health District compared to controls) respectively. 
This is another independent risk factor that is associated with low socio-economic 
status of the study population. This finding was statistically significant (p<0.05). 
Although TB treatment is a free service, out of pocket expenses for travelling and 
food have a bearing on treatment adherence. Patients have no choice regarding the 
predicament they find themselves in, as they did not invite these circumstances upon 
themselves,  however, such economic factors contribute to not completing TB 
therapy within the six-month period, and these factors are external to the health 
system. The results of this study agree with the previous research findings. 
This is comparable to the findings of a case- control study conducted in Timor and 
Role Island, Indonesia, which enrolled 121 cases and 371 controls showed that 87% 
of patients had malnutrition compared to 33% among controls (Pakasi et al., 2009). 
Results of systematic reviews conducted in 2008 show that poor nutrition at time of 
diagnosis worsens treatment outcomes (Lonnoroth et al., 2009). 
The findings of another case-control study (1055 cases and 2110 controls), 
conducted in South Africa in 2002 highlighted that cases were more likely than 
controls to report having to take TB treatment on an empty stomach (OR 1.6, 95% 
CI: 1.2-2.3) (van der Walt et al., 2002). An article review also highlighted that when 
the food is not available patients may not take TB treatment (Naidoo et al., 2007). 
One of the objectives of the study was to assess the socio-demographic 
characteristics of the patients with poor TB treatment outcomes. The results of this 
study agree with the existing evidence from previous research, which highlight that 
poverty is an important influence on health, and despite continuing economic growth 
in South Africa, poverty and health inequalities persist. Lack of food is an 
independent risk factor to adherence to TB therapy in this study. 
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 Residential Area 
This study found that a high proportion of cases (lived in rural areas,) Multivariate 
analysis showed a statistically significant association between living in a rural area 
and non- adherence to TB therapy (OR 14.3; 95% CI: 11 to 18). 
This is a reflection of the geographical distribution of the population. There are seven 
sub districts in Umgungundlovu Health District. Only one sub district is classified as 
urban, and four of these are situated in deep rural regions. The study also found that 
adherence to anti- tuberculosis therapy remained a challenge amongst the rural 
population, particularly in terms of access to health centres. Living in a rural area, 
though not a patient’s choice overburdens patients as they are in worse situations 
compared to those living in urban settings. The findings of this study corroborate 
other observational studies. 
In an unmatched case- control study conducted in Uganda between March and May 
2009 distance from home to clinic was identified as one of the factors associated 
with defaulting from TB treatment (OR 4.2; 2.2 - 8.0) (Elbireer et al., 2011).In a 
retrospective study conducted in Ghana default from treatment was significantly 
associated with living in communities far from the treatment centre (Dodor et al., 
2004). In a study conducted in Ireland socio-economic status has also been found to 
greatly impact on a person's access to effective healthcare (Luddy, 2007). 
The findings of a multi- faceted retrospective descriptive case study conducted at a 
Regional hospital and its three feeder clinics in Umgungundlovu Health District in 
2007 highlighted that, the clinic was too far to reach and transport was either 
expensive or unavailable (Loveday et al., 2007). The majority of the participants 
hailed from the poor rural settings in this study. The clinics in which the study was 
conducted are spread throughout these sub districts of Umgungundlovu Health 
District. 
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                      Type of house 
This study found that the proportion of cases who lived in a mud house was higher, 
compared to fewer controls. There is strong association between living in a mud 
house and treatment default (p<0.05). Living in a mud house is an indicator of low 
socio-economic status of the participants. This factor combined with other adverse 
factors such as unemployment and living in rural area, exacerbates the economic 
hardship that the patients face. 
This finding is comparable to the results of a retrospective study conducted in Peru 
which demonstrated that substandard housing conditions (hazard ratio, 1.8; 95% CI, 
1.1-3.1; p =0.03) predicted default from therapy in a multivariate analysis (Muniyandi 
et al., 2008). They further highlight association between TB and poverty in terms of 
income, standard of living, house type and social class. 
This finding is linked to low socio-economic status of the study population, which is 
an independent risk factor for non-adherence to TB therapy. This study did not 
investigate the conditions of the houses in which these patients dwell, but it could be 
assumed that the houses owned by non-adheres were in a poor state. 
                    Water source 
This study found that the majority of patients were drawing water from community 
taps and the proportion was higher among cases compared to adherers (60%) in 
Umgungundlovu Health District. This study showed statistically significant 
association between poor access to water supply and treatment default This is one 
of the independent factors that are indicative of low socio-economic factors(p<0.05). 
The findings of this study are in line with the result of a case study conducted in 
Umgungundlovu District in 2010, which identified huge backlogs in the delivery of 
services such as water and electricity services (Makhathini, 2010). Poor access to 
water is one of the indicators of low socio-economic status, and therefore an 
independent risk factor for non-adherence to TB therapy. 
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                  Sanitation 
The present study revealed that a proportion of cases using pit toilets was much 
higher compared to controls. There was statistically significant association between 
using a pit toilet and non-adherence (p<0.05). This variable, combined with other 
factors predispose patients to extreme levels of poverty, which causes them not to 
adhere to TB therapy. 
The findings of this study corroborate the results of a case study conducted in 
Umgungundlovu District in 2010, which identified huge backlogs in the delivery of 
services such as sanitation services (Makhathini, 2010).This is also one of the 
independent factors that determine the poverty levels of clients who default 
treatment in Umgungundlovu Health District. 
Alcohol 
This study revealed that majority of the cases consumed alcohol whilst they were on 
TB therapy compared to controls  in Umgungundlovu Health District., This was  
statistically significant (p=0.03). There is an association between drinking alcohol 
and treatment default. This is attributed to the fact that irresponsible drinking of 
alcohol will lead to persons not being responsible enough to take responsibility for 
their own health. It therefore becomes a challenge to even keep clinic appointments.  
The findings of this study corroborate the results of a case-control study conducted 
in South Africa in 2002, which indicated that among those who used alcohol, cases 
(68%) reported heavier alcohol drinking than controls (41%), (van der Walt et al., 
2002). The findings of this study are in contrast with the results of a surveillance 
conducted in Kazakhstan during 1995 to 2002, which showed that unfavourable 
treatment outcome of new TB patients was associated with alcohol abuse 
(Bumburidi et al., 2006). 
Findings of a retrospective study conducted in Kasturba hospital showed that 
alcoholism is a risk factor although it is a lower proportion (13%) of TB patients that 
consume alcohol compared to this case-control study (Gupta et al., 2011). In a 
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retrospective cohort study conducted in Tomsk on 237 adult patients, results showed 
that there existed no statistical significance between cases and alcohol dependence 
(95% CI 2.3-17.7) (Gelmanova et al., 2007). 
Results of systematic reviews conducted in 2008 showed that alcohol abuse 
increases the risk of TB about three- fold. This factor is due to the increased risk of a 
negative social mixing pattern and social drift (Munro et al., 2008). 
It is a logically deducted fact that if some of the money received by TB patients from 
a temporary disability grant of R750 a month was used to buy inter alia alcohol, such 
patients who consume alcohol will consequently be less likely to possess any money 
for transport. Such an impact will invariably lead to treatment default.  
Lack of statistical significance of alcohol abuse between cases and controls in this 
study could be attributed to under reporting by study participants.Systematic studies 
using standardized and validated alcohol assessment instruments will be needed to 
ascertain the full impact of alcohol disorders on patients’ ability to comply with TB 
treatment. 
    Smoking 
The present study showed that a quarter of cases () were current smokers, the 
majority of whom were males, compared to a smaller proportion of controls. ). There 
was statistically significant difference between cases and controls (p=0.01). This 
finding could be explained by the fact that patients were smokers even before they 
contracted TB. Smokers are more likely not to complete TB therapy within the six-
month period than non-smokers are, particularly if they are poor. The little money 
they get might be used to feed their smoking habit than being spent on transport to 
collect TB medication from the clinic. The results of this study corroborate previous 
studies conducted in different settings. 
In a cohort study conducted in Malaysia the rate of default was higher among 
regularly smoking TB patients compared to those who never smoked (12.8%; 35/274 
vs. 2.0%; 5/250, respectively) (Dujaili et al.,2010). After controlling for confounders, 
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including age, sex, alcohol use, Intravenous drug use (IVDU) and a history of chronic 
disease, ever smokers were three times more likely to default from treatment 
compared to never smokers.(3.24) Another study conducted in South India indicated 
that smoking was significantly associated with treatment failure (Gupta et al., 2011). 
There could have been under reporting of smoking status by the participants in this 
study. 
                   Drug Abuse 
This study showed that more cases who abused drugs whilst receiving TB treatment 
compared to controls in Umgungundlovu Health District. There is statistically 
significant association between drug usage and non-adherence to TB therapy 
(p<0.05).This percentage could be higher; the assumption is that a social desirability 
bias might have influenced the response of participants to this question, as it is a 
sensitive issue. 
A most probable reason thereof can be ascribed to not answering truthfully. Drug 
abuse, a category which includes dagga, pills and most recently whoonga is rife 
especially in poor communities in UMgungundlovu Health District. The participants 
admitted using these substances. These patients are most likely to default treatment 
as getting drugs becomes their first priority than worrying about taking TB treatment. 
This irresponsible behavior contributes indirectly to non-adherence to TB therapy, as 
they lack money for other important things like travelling to the clinic to collect TB 
medication. 
The findings are in agreement with other observational studies elsewhere. In a 
multivariate model, substance abuse was identified as the only factor that was 
strongly associated with non-adherence, an odds ratio of 15.6 (95% CI: 3.5–70.1) 
was obtained. Findings of a retrospective study conducted in Morocco on 291 
patients identified male sex, as one of the principal risk factors for default (Dooley et 
al., 2011). 
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This discovery is further supported by findings of the systematic review which state 
that alcohol and injection drug use were the only independent risk factors for non-
adherence and default that we identified (Creswell, 2011).  
Findings of a cross-sectional study conducted in the United States showed that odds 
of treatment failure were 2.4 times greater among those who reported substance 
abuse (Oeltmann et al., 2009). These findings resound in those of numerous 
previous studies that had found substance abuse to serve as the single major factor 
associated most strongly with non-compliance with TB regimens. 
Conversely the findings of a case- control study conducted in South Africa in 2002 
indicated that only a small proportion of patients, both among cases (6%) and 
controls (4%) reported drug usage (van der Walt et al., 2002). 
Directly Observed Treatment  
  Access to Directly Observed Treatment  
This study revealed that both cases and controls had equal access to DOT support. 
There was no statistically significant difference between the two groups (p=0.54). 
Although both cases and controls had access to DOT, the major differences became 
manifest around the choice of DOT support and the frequency thereof. 
The results of this study are comparable to the findings of a retrospective study 
conducted in KZN, South Africa to evaluate the DOT programme undertaken in 
EThekwini, UMgungundlovu, UMzinyathi and UThungulu districts showed that on 
average, priority facilities in districts that have high DOT coverage exhibited better 
cure rates compared with those that have low DOT coverage (p=0.04) (Ntshanga et 
al., 2009). 
Conversely the findings of a cross sectional study conducted in Nigeria revealed that 
accessibility to DOT services was still suboptimal and it was worse among the rural 
dwellers, most of who are poor and living several kilometres from DOT service 
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centres (Fatiregun et al., 2010). This study found that DOT coverage was good and 
is not centralized to health centres, but is more community based. 
       Choice of Directly Observed Treatment 
This study showed that the majority of TB patients) who made their own choice of 
DOT supporters had better treatment outcomes because of adherence to TB 
treatment, whereas cases had DOT supporters chosen by the health worker. There 
was statistical significance in terms of DOT supporters, (community health workers) 
that were allocated to the patient by the health worker, compared to the patient’s 
own choice (p<0.05). 
Patients who had chosen their own DOT supporters were more likely to have a 
successful TB treatment outcome because of adherence to treatment compared to 
those who did not make the choice. This could be attributed that these patients 
would choose people who are reliable and they have a trusting relationship with, 
instead of relying on strangers as DOT supporters. 
This study demonstrated that approximately a higher proportion) of the cases had 
CHWs as DOT supporters, whereas the majority of the controls had family members 
as DOT supporters. Those who had family members as DOT supporters also 
demonstrated a better chance of completing treatment successfully within six 
months, .compared to cases.  This was statistically significant (p<0.05). 
The results of the present study corroborate the findings of a prospective cohort 
study conducted in Thailand which highlight the fact that the pattern of drug 
administration impacted on treatment success. Family-based DOT had the highest 
success rates compared with centre based DOT (OR 20.9, 95% CI 5.0-88.3) 
(Kamolratanakul et al., 2009). 
Conversely the findings of a retrospective cohort study conducted in KZN in 2008 
demonstrated that TB patients who had workplace based DOT had the best 
treatment outcomes that were statistically significantly (p<0.01) better than family 
member supported DOT (Nair et al., 2010).Yet another retrospective study 
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conducted in Cape Town, South Africa, demonstrated that community health worker 
support contributed to better TB control programme performance than an approach 
based exclusively on health facilities (Dudley et al., 2011). 
Findings of a cluster randomised controlled trial conducted in Nepal however found 
that community DOT support and family-member based DOT support achieved 
success rates of 85% and 89% respectively (Newell et al., 2006). 
Contrary to the above findings, the results of a retrospective cohort study conducted 
in Tomsk, Russia showed that despite the implementation of a DOT programme and 
the provision of extensive social services to patients undergoing TB therapy, non-
adherence and default continued in a substantial proportion of those who initiated 
treatment (Gelmanova et al., 2007). 
Furthermore, findings of a multi- faceted retrospective descriptive case study 
conducted at a Regional hospital and its three feeder clinics in Umgungundlovu 
Health District in 2007 suggest that there were no systems for support, monitoring 
and evaluation of the treatment supporters and other cadres of workers, and there 
was no uniform system of training (Loveday et al., 2007). 
Findings of this current study, which showed better treatment support by family 
members compared to other forms, indicates diversity of opinion by researchers 
about which approach works best in different settings and situations among 
researchers. This opens another opportunity for further research. 
Frequency of DOT support 
This study showed that ( cases had less frequent contact with DOT supporters 
ranging from weekly to once a month intervals respectively compared to controls  
These were more likely to interrupt or default compared to patients that had DOT 
support on daily basis for a high proportion of controls (compared to that of cases  
which proved to be very effective. This was statistically significant (p<0.05). 
This study showed that those who received DOT support on a daily basis were able 
to complete treatment successfully, compared to those who had DOT support weekly 
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or occasionally. It is not feasible for CHWS to supervise treatment regularly as they 
are allocated a number of households to visit, and they only work 22 days a month. 
Although this factor is not the patients’ choice, the situation they find themselves in 
contributes to non-adherence to TB therapy. Patients who have frequent DOT 
support stand a better chance of adhering to TB treatment, resulting to being cured 
within six months, whereas patients who have less frequent contact with DOT 
supporters are more likely to interrupt or default treatment. 
A significant observation in support of this finding was made in the descriptive study 
conducted on 216 new adult TB patients in South Africa in 2006, whereby successful 
treatment outcomes were significantly associated with treatment supporters having 
fewer than 10 patients (Odour, 2006).  
The less frequent coverage for cases that are mostly supported by CHWs could be 
attributed to shortage of DOT supporters. This study did not investigate the number 
of community DOT supporters allocated per clinic versus number of current TB 
patients in the register as well as their availability. 
Self-Administered Therapy 
This study demonstrated that there was no significant difference in treatment 
outcomes on patients that are supervising their own treatment between cases and 
controls (and this was not statistically significant (p=0.500). There was a smaller 
proportion in both groups who opted to administer their own treatment. This was 
probably determined by their own personal circumstances, whereby some of them 
live on their own and there is no support system around them. 
Conversely the findings of an unblinded randomized controlled trial conducted in 
South Africa showed that treatment for tuberculosis was more successful among 
self-supervised patients (60% of patients) than among those on DOT (54% of 
patients, difference between groups 6%; 90% CI 5.1-17.0) (Zwarenstein, 1998). 
The findings of another retrospective study conducted in the  United States of 
America on 372 TB patients showed that patients treated by DOT at the start of 
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therapy (n=149) had a significantly higher cure rate compared with patients treated 
by SAT (p<0.002) (Jasmer et al., 2004). 
The findings of this study indicate that the DOT programme can be beneficial if 
implemented correctly and with some degree of patient choice. It is for this reason 
that the Department of Health is currently reviewing the CHW policy with the view to 
replace Community health Workers with Community caregivers who will provide 
holistic care to communities instead of various groups undertaking different 
interventions in one household. The new strategy is being piloted at Umgungundlovu 
Health District in 2011. (Personal communication and involvement May 2011). 
        HIV and AIDS 
                HIV Status 
This study showed that a higher proportion of cases had TB- HIV co-infection 
compared to fewer controls. There was a statistically significant association between 
people living with HIV-and unsuccessful TB treatment outcome, related to non-
adherence to TB therapy (p<0.05). These findings are lower than the current trends 
where TB co-infection is about 70% in South Africa. The burden of TB/HIV co-
infection contributes to non-adherence to TB therapy, especially if it is coupled with 
poverty. If patients have no food to eat, they are less likely to adhere to TB treatment 
if they have to take it on an empty stomach as it causes more nausea and 
sometimes vomiting. 
The result of this study corroborate the findings of a retrospective study conducted in 
California on 700 patients which revealed that 264 (38%) were HIV infected. Relapse 
rates were found to be significantly higher in HIV-infected patients compared with 
HIV-uninfected patients following a Rifamycin-based regimen. Furthermore, TB 
relapse rates were higher in HIV-infected patients who received intermittent or 
standard 6-month therapy when compared with those receiving daily or longer 
treatment (Nahid et al., 2007).  
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The findings of this study are also slightly higher than the findings of another 
prospective study conducted in Cape Town, South Africa showed that 238 (25%) of 
patients enrolled for ART programme had prevalent TB (Lawn et al., 2006). 
A retrospective study conducted in South India on 207 patients showed that 10.6% 
of TB patients were living with HIV, which is even much lower that the finding of this 
study. It further highlights that relapse rates were found to be significantly higher in 
HIV-infected patients compared with HIV-uninfected patients following a Rifamycin-
based regimen (Gupta et al., 2011). Furthermore, TB relapse rates were higher in 
patients living with HIV who received intermittent or standard 6-month therapy when 
compared with those receiving daily or longer treatment (Nahid et al., 2007). 
Contrary to this finding, a prospective diagnostic study conducted in South Africa on 
534 adult TB patients showed that 73% were living with HIV. Findings of a population 
based cross-sectional study conducted in South Africa showed that overall 55.3% of 
TB patients were also living with HIV. Female patients had significantly higher rates 
of HIV when compared to males. (62.2% versus 51.5%) (Shah et al., 2011). 
The findings of a multi- faceted retrospective descriptive case study conducted at a 
Regional hospital and its three feeder clinics in Umgungundlovu Health District in 
2007, showed that there are increasing numbers of TB and HIV co-infected patients 
who have higher mortality and morbidity and are more difficult to diagnose and treat 
at a PHC level, due to smear-negative PTB, EPTB (Extra pulmonary TB) or MDRTB 
(Multidrug resistance) (Loveday et al., 2007). 
This outcome is echoed by the findings of a retrospective cohort study conducted in 
Spain in 1996-1997, which state that the outcome for tuberculosis treatment greatly 
deteriorates in HIV-positive patients (Diez Ruiz et al., 2005). 
This study demonstrated an association between HIV status and MDRTB, as well as 
the poor state of health occurring among cases. Findings of this study are 
comparable to a routine surveillance conducted in Virginia highlighted that those 
patients living with HIV are prone to malabsorption and are at higher risk for low drug 
levels (Heysell et al.,2010). 
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The rate of TB and HIV co-infection among cases was found to be associated with a 
poor treatment outcome. The combination of these factors will inevitably negatively 
affect adherence to treatment resulting in poor treatment outcomes. Such a 
compromised situation is exacerbated by adverse socio-economic factors as 
described earlier. 
Severity of Illness  
       Treatment Default, Number of Months and Reasons 
This study found that a high proportion of the cases interrupted or defaulted 
treatment, and the majority of them had interrupted treatment for one month whilst 
others had defaulted treatment for two (19%) and three months (1.3%) respectively, 
and this was statistically significant (p<0.05). Overall default rate was found to be 
much higher in Umgungundlovu Health District than the WHO recommended rate of 
3%. 
The main reasons provided by participants in this study concerned were lack of 
money and illness, as well as risky behaviours, such as alcohol, drugs and smoking. 
Such a finding proves that there exists a strong correlation between socio-economic 
status and adherence to TB treatment. Poverty acts as a major barrier in accessing 
health care. Illness as a barrier could be attributed to TB and HIV co-infection, as 
44% of cases had exhibited HIV co-infection. 
The results of this study also agree with the findings of previous studies that non-
adherence exerts certain important adverse effects on the outcomes of TB 
treatment. All poor outcomes occurred among patients who did not adhere to TB 
therapy. The results of this study showed a higher proportion of patients who 
defaulted compared to a retrospective study conducted in Ethiopia, which showed 
that 61% defaulted (Munoz-Sellart et al., 2010). In a retrospective cohort study 
conducted in Nigeria the default rate was slightly lower (14.4%) (Ogboi et al., 2010). 
Results of an article review conducted in South Africa also highlight the fact that 
treatment adherence is also affected by beliefs concerning the origins of and 
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transmission means of TB and HIV (Naidoo et al., 2007). This current study agrees 
with the findings of other researchers elsewhere.This study was a retrospective 
case-control, therefore cases were enrolled on the basis of not having completed 
treatment successfully hence the higher proportion of cases compared to other 
studies. 
MDRTB Positive 
This study revealed that 4a proportion of cases were MDRTB positive in 
Umgungundlovu Health District, and this was statistically significant (p<0.05). These 
were included in the analysis as they had defaulted treatment at some stage during 
the six month period of TB therapy.   
The proportion of MDRTB cases was slightly higher than (10.0%) on a retrospective 
study conducted in Peru ( Findings of an earlier study conducted in 1999 in South 
Africa showed that the prevalence of primary and acquired MDRTB was 1.8% and 
4.1% respectively (Davies et al., 1999). 
Findings of a retrospective study conducted in Ghana suggest that these patients 
may harbour multiple different strains of Mycobacterium TB, some of which may 
indeed prove to be drug-resistant. In these mixed infections, standard short-course 
therapy may have unmasked the drug-resistant strain population by suppressing the 
previously dominant drug-sensitive strain (Dodor, 2004). 
This study found the incidence rate of MDRTB slightly lower than the findings of a 
cross-sectional study that was conducted in KwaZulu Natal on 20858 patients, which 
showed that 20% of them had MDRTB (Moodley et al., 2011). The results of 
surveillance conducted in rural South Africa from 2005 to 2006 found that the 
prevalence among patients with culture-confirmed tuberculosis was 39% for MDRTB 
(Ghandi et al., 2006). However, the results of a retrospective study conducted in 
Umgungundlovu Health District which showed that the number of MDRTB case per 
100 new cases was 14.8%, which is similar to the findings of this study (Sturm, 
2010). 
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Findings of a retrospective observational study conducted in KZN, South Africa, in 
2002-2003 revealed that 80% of MDRTB patients were HIV co-infected (Brust et al., 
2011). In another retrospective study conducted in rural KZN, South Africa the 
results showed that 78% of MDRTB cases were living with HIV. 
In a retrospective cohort study conducted in California on 700 patients, 264 (38%) 
were HIV infected and were significantly more likely to develop drug resistance 
(4.2% in HIV-infected versus 0.5% in HIV-uninfected) to rifampicin, and to 
experience adverse reactions to TB regimens (Nahid et al.,2007). This study did not 
assess the percentage of patients living with HIV who had MDRTB. 
Physical Status during TB treatment 
This study found that a higher proportion of cases indicated that they remained very 
ill after being diagnosed with TB compared to controls. There is a statistically 
significant association between being very ill during TB therapy and non-adherence 
to TB therapy on multivariate analysis (p<0.05). Patients who were feeling ill during 
TB therapy were more likely to default treatment as they would perceive that the 
treatment is making them worse. Being very ill combined with poverty would cause 
patients to delay to seek health care intervention thus exacerbating the condition. 
The findings of this study are comparable to other studies elsewhere.The findings of 
a multi- faceted retrospective descriptive case-control study conducted at a Regional 
hospital and its three feeder clinics in Umgungundlovu Health District in 2007, 
highlighted  as one of the factors that respondents were either too sick to physically 
access the clinic (Loveday et al., 2007). Another retrospective cohort study 
conducted in India on 980 patients showed that good health status was only 
perceived in less than 7% of patients. Physical condition was found to be an 
independent risk factor for non-adherence to TB therapy in this study. 
                  TB treatment and side effects 
This study showed that a higher proportion of cases reported TB treatment side 
effects mainly nausea compared to controls. This result was statistically significant, 
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indicating association between treatment side effects and non-adherence to TB 
therapy (p<0.05). Participants who did not report side effects were most likely to 
adhere to therapy compared to those with side effects. 
The results of this study are comparable to the findings of a case-control study in 
China which showed the presence of adverse effects during treatment on 46.5% 
cases (Xianqin et al., 2010).This is lower than the findings of this study and even 
lower in the study conducted in Switzerland in 2009 using a retrospective review of 
medical records, which revealed that drug related side effects were noted in 75 
cases (30%), however side effects severe enough to change or stop treatment were 
reported in only 38 cases (15%) (Kherad et al. 2009) compared to the study 
population in Umgungundlovu Health District. 
In an unmatched case control study conducted in Uganda between March and May 
2009 the side effects of treatment (OR 5.53; 2.25–13.61), was highlighted as a factor 
contributing to treatment default (Elbireer et al., 2011). Results of a paper review 
conducted in South Africa highlighted that, complex regimens with potentially severe 
side effects cause non- adherence (Munro et al., 2007). 
This is further supported by results of a systematic review which state that anti-
tuberculosis medication side effects were also found to be significantly associated 
with defaulting, and were responsible for termination of therapy in up to 23% of 
patients during the intensive phase (Awofeso, 2006). Treatment side effects were 
found to be an independent risk factor for non-adherence to TB therapy in this study. 
 Other, Health Seeking Behaviour, Knowledge, Attitudes and Practices 
All respondents felt that they experienced good treatment at the health facility and 
did not feel stigmatised because they had TB. Thus, it is unlikely that poor treatment 
at clinic level was the factor responsible for non-adherence. It is also unlikely that a 
social desirability bias prompted patients to minimise dissatisfaction with the health 
service because interviewers were not clinic staff. 
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It is, however, important to note that there were contrasting findings in a multi- 
faceted retrospective descriptive case study conducted at a Regional hospital and its 
three feeder clinics in Umgungundlovu Health District in 2007 as the perception 
among respondents was that they were stigmatised by some health workers and 
were not treated with respect (Loveday et al., 2007). 
Type of alternative medicine and practitioner consulted 
This study found that a significant proportion of cases resorted to alternative 
medicine and a traditional healer was most commonly consulted, followed by a 
diviner, compared to controls, and this was statistically significant (p<0.05). These 
practitioners are easily accessible compared to the health centres and their services 
are less onerous financially.  
However, this practice could have contributed to a high defaulter rate, if patients had 
perceived that these alternative medicines were potentially helpful in alleviating 
certain symptoms. Other respondents (albeit a lesser percentage) consulted a 
homeopath, or a faith healer. These practitioners are probably not readily available 
or accessible in the area where the study was conducted. The findings of this study 
are supported by those of other researchers’. 
The findings of a multi- faceted retrospective descriptive case study conducted at a 
Regional hospital and its three feeder clinics in Umgungundlovu Health District in 
2007 highlighted the fact that a quarter of the patients had consulted a traditional 
healer on occasions during their illness, after their knowledge of their TB status. 
Sixteen per cent of the patients visited a traditional healer as their first choice of 
care. Of those in the latter category, (72%) were male (Loveday et al., 2007). This 
study did not analyse the gender distribution of patients that use alternative 
medicine. 
The findings of this study also corroborate the results of a case-control study 
conducted in South Africa in 2002, which indicated that cases (17%) were more 
likely than controls (7%) to report consulting a traditional healer during TB therapy 
(OR 2.8, 95% CI: 1,7-4.3) (van der Walt et al., 2002). 
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Researchers further state that two thirds of the home remedies used originated from 
a chemist or supermarket and one third from a traditional healer/herbalist or 
traditional chemist. Sixteen per cent of the patient’s interviewed consulted a 
traditional/spiritual healer. Fifteen per cent of the TB patients went to a 
spiritual/traditional healer. A quarter of the respondents visited a traditional 
healer/spiritual healer/ herbalist at some stage during their illness (i.e. either before 
or during). Use of alternative medicine during TB therapy was found to be an 
independent risk factor for adherence to TB therapy in this study. 
             Tuberculosis Knowledge 
This study found that all respondents from both groups , cases and controls knew at 
least 4 signs and symptoms of TB as well as the TB mode of transmission, and the 
majority indicated that the most reliable source of information were the health 
workers. There was no statistically significant difference between these groups in 
terms of knowledge of TB signs and symptoms as well as mode of transmission 
(p=0.500). Prompts that were provided in the questionnaire would have contributed 
to high knowledge levels than when participants were unprompted. 
This conclusion also bears testimony to the fact that a lot of groundwork has been 
covered in intensification of TB awareness in the community, which includes a TB 
blitz, which involves a community meeting hosted by health workers with various 
activities to raise TB awareness. Door to door campaigns, which include household 
visits and distribution of pamphlets, have been implemented in Umgungundlovu 
Health District on a continuous basis. (Umgungundlovu Health District Report 2010) 
The results of this study are comparable to the findings of a multi- faceted 
retrospective descriptive case study conducted at a Regional hospital and its three 
feeder clinics in Umgungundlovu Health District in 2007, which showed that over 
90% of the patients, were fully cognisant of the fact that TB was curable and taking 
medication was important. Patients, however, felt that information from health care 
providers remained the most trustworthy source of relevant and appropriate 
guidance (Loveday et al., 2007). 
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A contrary conclusion was witnessed in a population based cross sectional study 
conducted in the rural community in Vietnam highlighting the fact that a large 
proportion of the general population possessed only a limited knowledge of TB, 
despite many years of health education (Hoa et al., 2009). Such differences are 
significant as they provide an opportunity for further research. 
This study however revealed that the knowledge of TB drugs was very poor among 
the majority of cases, even with prompting. There was a statistically significant 
association between non-adheres and lack of knowledge of TB drugs (p<0. 05). It 
would appear that this is linked mainly to the low literacy levels of participants or their 
lack of interest in being fully informed of the medication they were receiving.  
 Distance to Clinic, in Kilometres and Taxi fare in Rands 
This study showed significant difference between cases and controls in terms of the 
distance travelled from home to the clinic in Umgungundlovu Health District (p<0.05). 
Cases had a median of 16 to 55 km to travel to the health facility and between R14 
to R40 spent on travelling costs. This is linked to the socio-economic status and rural 
setting, and it contributes indirectly to non-adherence Patients who are already poor 
are overburdened by the travelling costs to the clinics and are most likely to default 
treatment than those who have means. Although this factor is also not the patients’ 
choice, it points to the external patient-related factors that the health system has no 
control of. 
The findings of this study are comparable to a qualitative study conducted in Zambia 
on 202 adult patients with TB showed that within a poor resource setting, patients 
face financial constraints, specifically regarding travel distances and related 
transportation costs, factors which create a significant burden on patients (Needham 
et al.,2004). Findings of this study are also in line with results of a retrospective study 
conducted in China on 190 new smear- positive TB patient showed that the distance 
from home to a Health Centre were significantly associated with a delay in seeking 
care from service provider (OR 1.04; 95% CI 0.64-1.28) (Cheng et al., 2004). 
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In a retrospective study conducted in Ghana default from treatment was significantly 
associated with living in communities far from the treatment centre (Dodor, 2004). In 
a study conducted in Ireland socio-economic status has also been found to greatly 
impact on a person's access to effective healthcare (Luddy, 2007). Results of 
another systematic review conducted in Nigeria showed that accessibility to DOT is 
sub-optimal among rural dwellers, most of who are poor and live several kilometres 
from health centres (Amoran et al., 2011). Long distance and transport costs were 
found to be independent risk factors for non-adherence to TB therapy in this study, 
as they both hinder access to health facilities. 
 Number of People in the Household and Number of Sleeping Rooms 
This study showed that a high proportion of cases shared the sleeping rooms with a 
large number of people, median 18, whereas the median for controls is 8 in 
Umgungundlovu Health District. This was statistically significant as one of the risk 
factors for treatment default (p<0.05). 
This finding is linked to socio-economic status of the majority of TB patients who are 
burdened by poverty. Overcrowding itself is a risk factor for the spread of TB in one 
household. If they are more people infected in one family, it increases the chances of 
non-adherence to TB therapy because of the socio-economic conditions they find 
themselves in, which prevents them from keeping clinic appointments. 
This finding is comparable to the findings of systematic reviews conducted in 2008 
which showed that the risk of TB increased with lower socio-economic status as 
regards six indicators: crowding, education, income, poverty, public assistance and 
unemployment (Lonnoroth, 2011). Large numbers of people in one household is 
linked to the poor socio-economic status in this study. Poverty is an independent risk 
factor to adherence to TB therapy in Umgungundlovu Health District. 
Major Risk Factors 
After controlling for confounding, five major risk factors associated with poor 
treatment outcomes were identified in Umgungundlovu Health District. These were 
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unemployment, living in a rural area, living far from the local clinic, being HIV 
infected, and being very ill while taking TB treatment. 
Validity 
This section discusses internal validity of the study, which refers to whether the 
outcomes of this study are a function of the dependent and independent variables 
measured. The external validity section considered generalisability of the study 
findings to the population. 
                                            Internal Validity 
There were two data sources that were used to determine risk factors to poor TB 
outcomes with specific reference to treatment default. The primary source of data 
was TB patients themselves and some data like MDRTB status, treatment 
interruption; treatment default was extracted from the TB register and TB carrier 
cards. 
Data that was supposed to be extracted from patients was missing in some 
instances from the questionnaires, but this not affect the measurement as it 
comprised of only two percent. Approximately four percent of the participants chose 
not to respond to certain questions. The questionnaire was quite long and some of 
the questions might have made respondents uncomfortable to respond to, especially 
if they are asked personal questions by strangers. 
Responses on exposures like HIV infection, smoking, alcohol intake, drug use and 
alternative medicine were based on the truthfulness of each participant, there could 
have been under reporting. HIV status is not recorded in the patient cards and this 
was common practice in all clinics. This can be explained by the fact that all new TB 
patients are diagnosed, tested for HIV and initiated TB treatment at a hospital level 
and they are thereafter referred to their nearest clinics for follow up and collection of 
their treatment under the supervision of professional nurses. 
 Field workers themselves might have made an error in recording and missed some 
data. This could have been prevented if interviews were recorded by tape as well. It 
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would have been cumbersome to record 600 interviews, and participants were 
perhaps not going to respond freely knowing that they were being recorded. 
                                        External Validity 
Umgungundlovu Health District is the second most populous district in KZN province. 
The study population comprised 600 participants selected from only 15 out of 42 
clinics. The results of this study are t generalisable to the TB patient population in 
South Africa. The results can be generalized to new TB patients who attend the 
clinics in rural clinics of South Africa as the sample size was adequate. 
Bias and Limitations 
The bias and limitations of this study are discussed with regards to the design, data 
collection and the findings of the study. 
Although this retrospective study demonstrates the significant risk factors associated 
with non-adherence to TB therapy in Umgungundlovu Health District, this study is 
not without limitations. The major limitation to this study was that it was conducted 
retrospectively, and it therefore relied on the truthfulness of the respondents and 
accuracy and completeness of data entered by 12 field workers on the 
questionnaires. Recall bias was a limitation in this study. Accuracy of data was 
dependent on how best the respondents were able to recall certain facts. 
Another limitation of this study was the social desirability bias. It was not possible to 
ascertain accuracy of information on risk factors like alcohol intake, smoking and 
drug use, use of alternative medicine during TB therapy although study participants 
were assured of confidentiality and anonymity, and the fact that data was collected 
for research purposes only. 
Funding for the study was a limitation. The initial proposed budget proved to be 
insufficient as the actual data collection only took place two years after the estimates 
were compiled, following the approval by the Ethics Committee. The major costs 
were around sustenance costs for the 12 field workers, which included transport and 
food. These costs were met by the researcher, including her own transport costs to 
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visit study sites to monitor data collection. The advantage was that other study sites 
were within reach and in close proximity to each other. There were no incentives for 
the study participants, which could have increase the budget demand. The costs of 
the research project were however curtailed by the fact that a case-control study is 
simple and cheap to administer. The statistical analysis of this study was conducted 
by the researcher under the supervision of a biostatistician at the University of 
KwaZulu-Natal. 
Summary 
This chapter discussed the statistical significance of demographic and socio-
economic factors, as well as health status and health seeking behaviour associated 
with unsuccessful TB treatment outcomes. Drug abuse was identified as being the 
only risky behaviour associated with poor treatment outcomes and one of the factors 
leading to non-adherence of TB treatment in Umgungundlovu Health District, while 
alcohol and smoking were not found to be independent risk factors. 
The combination of these factors bore a casual relation to higher proportions of 
cases reporting that subjects were very ill during the TB treatment period. This 
contributed to treatment default and lack of money for transport to the clinic and 
impacted on the treatment outcomes. DOT support proved to be a limitation in terms 
of frequency. Cases were not able to receive daily DOT support compared to 
controls. This also affected adherence to treatment. 
These patient-related factors indicate that the health system is faced with a huge 
challenge in TB control. The  comparison   with other study findings indicate that the 
challenges faced by the South African TB programmes are not unique, and that the 
recommendations and changes made to those programmes are as a result of their 
studies need to be taken into consideration locally. There is enough evidence to 
indicate that most of the factors highlighted are significantly associated with non-
adherence to TB treatment including  unemployment, living in a rural area, living far 
from the local clinic, being HIV infected, and being very ill while taking TB treatment 
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all of which need to be considered when developing policies and plans to improve 
treatment uptake. 
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5 CHAPTER: CONCLUSIONS AND RECOMMENDATIONS 
Introduction 
This study has demonstrated the following: 
There are numerous patient related factors which have previously hindered the 
success of TB control programmes. These factors are of a complex and interrelated 
nature. The study assumed a holistic approach wherein it examined the multiple 
factors that interact upon each other to allow for either a successful or an 
unsuccessful outcome to be achieved. For example, in the low socio- economic 
group, the burden of TB may be high.  
Such a factor, together with the high incidence of TB and HIV, may lead to an 
increased severity of illness. This may cause patients to seek alternative medicine as 
traditional healers are more accessible compared to the clinics which are situated far 
from where patients live in rural areas. Patients are more likely to consult such 
healers rather than attend the clinic. This phenomenon is likely to increase the 
defaulter rate and lead to a poor treatment outcome in Umgungundlovu Health 
District. 
Conclusions 
The major risk factors associated with poor TB outcomes are unemployment, 
distance from home to clinic, living in rural areas, having TB and HIV co-infection 
and being very ill during treatment. 
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Figure 3: Diagram of interrelatedness 
The diagram above illustrates the infinite interplay of multiple factors which influence 
each other. 
The application of Bandura’s behavioural theory was appropriate in this study as the 
factors identified link to cognitive, social and environmental aspects. The aim and 
objectives of this study were achieved. The greatest benefit to patients is likely to 
come if many of these factors are addressed simultaneously, rather than addressing 
one at a time. Furthermore, it can be confidently asserted that the aim and objectives 
of this study were achieved. The study was adequately powered to ascertain the real 
differences. 
Recommendations 
It is important to review the definition of treatment interruption and treatment default 
especially in the context where non-adherence to treatment remains a challenge. 
Introduction of new and quicker ways of TB diagnosis is vital to reduce costly trips to 
the health facility. The Gene-Xpert machine should be available in most populous 
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of TB therapy, and to minimize number of trips to the health facility, which 
contributes to non-adherence. 
District Intervention strategies should prioritize the five major risk factors that 
contribute to poor treatment outcome, which were identified in this study. 
The current system of temporary social grants for TB patients needs to be reviewed 
jointly by the Department of Social Welfare and the Department of Health. These 
grants are meant to assist the poor to buy food and have money for transport to the 
health facility. However, the government retains no control on how this money is 
used by each individual. 
Furthermore, interpersonal communication with family members, among other 
strategies, linking poor and vulnerable populations with social welfare schemes will 
prove a significant benefit and aid in achieving treatment outcomes. Vouchers should 
be introduced for patient transport and food. Such a development will eliminate the 
problem of non –adherence because of a lack of money and food. The Department 
of Social Welfare is currently issuing vouchers to deprived families usually to the 
value of R800 a month, as part of social relief. The recipients merely proceed with 
the voucher to selected supermarket for groceries. 
These pro-poor strategies will go a long way to reducing the financial burden of 
patients on TB treatment. This will require that a full risk assessment be undertaken 
on each newly diagnosed TB patient so as to identify potential factors for non-
adherence. This should be done in conjunction with individualized patient 
counseling, which must be followed by individualized plan of taking six month 
therapy. The DOT strategy needs to be reviewed and implemented based upon 
circumstances applying to each patient. 
Incentives should be provided to patients that have adhered to the full course of 
treatment to encourage adherence. There exists an urgent need for health care 
providers to form a partnership with providers of alternative medicine. 
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Integration of HIV and AIDS, TB STI services should be implemented as a matter of 
urgency. Community based services should be strengthened through the new 
Sukuma Sakhe programme. Thus, one cadre of well-trained Community Care Givers 
will be introduced. It will be appropriate to initiate an SMS system for appointment 
reminders for patients who possess cell phones. This serves as one means of 
improving communication between health care providers and patients. Integration of 
TB in Education and care for HIV/AIDS (ITEACH) and Non- Governmental 
Organisation based at Edendale hospital has already introduced this form of 
communication for patients on ART. 
Strengthening of PHC services from community level to clinics is l imperative, as this 
remains the first point of contact with the patients, which is critical to ensure a proper 
assessment of risk factors that might lead to non-adherence to TB therapy.  This 
effort will reduce the number of new TB patients that are lost in the health system, 
while they should still be receiving treatment. The issue of allocating health posts 
closer to where people predominantly live will improve access to some basic health 
care, and is a matter requiring urgent implementation by the Department of Health. 
It is important to review a definition of interruption and default as the difference is 
merely technical. In reality if the patient interrupts treatment for one month that is 
already a precursor for treatment default. TB registers and patient cards ought 
mandatorily to include HIV information so as to ensure holistic care. Currently the TB 
referral form from the hospital to the clinic, and the patient TB card do not have 
space for the HIV status. 
New cost effective Community based TB prevention strategies are critical to reduce 
the burden of TB. These may include anti-smoking, anti-alcohol and anti- substance 
abuse interventions, which should be incorporated into TB community education and 
community involvement, must be encouraged in fighting these social behaviours. 
Community support groups for TB patients will most likely prove beneficial in 
encouraging compliance as is the case with patients on ART. Allocation of more 
resources to support the TB management programme is critical in order to improve 
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TB cure rate per annum. The 'opt' out choice of TB patients to health provider 
initiated HIV counseling and testing should be reviewed. 
Recommendations for Further Study 
Although the study investigated multiple risk factors that are associated with poor 
treatment outcomes, it would be beneficial to assess each of these variables closely. 
The proposed areas of further study should include: 
Investigation into the effectiveness of social grants; effectiveness of DOT; male 
patients and adherence to TB treatment; younger age group: 18-30 and adherence 
to treatment; TB and people living with HIV, patients lost to follow up; the burden of 
MDRTB; comparison between effectiveness of institutionalized and ambulatory TB 
control programme, smoking, alcohol and substance abuse as risk factors to 
adherence and use of alternative medicine and non-adherence to treatment. 
Summary 
This chapter summarized risk factors associated with non-adherence to TB 
treatment and poor treatment outcomes for new TB cases, which have been 
exposed to TB treatment for six months. After adjusting, the major risk factors 
identified were unemployment, living in a rural area, distance from home to the clinic 
where TB medication is collected on monthly basis, HIV infection and being very ill 
during treatment. 
Based on the results it was recommended that patient centred and community based 
interventions should be redesigned and implemented by health care providers in 
order to strengthen TB control programme in ambulatory care. Further research is 
also recommended, as the tendency in the previous studies has been to focus on 
individual risk factors that contribute to TB treatment outcomes, yet it is a number of 
factors that interplay to produce a poor outcome. They cannot be looked at in 
isolation. 
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Respondent: Any able and willing person above 18 who is a new case on TB 
treatment 
NB: ENSURE YOU HAVE A SIGNED CONSENT FORM BEFORE YOU BEGIN 
QUESTIONS TO BE DIRECTED TO RESPONDENTS 
Please Tick or circle relevant answer 
PART 1: SOCIO-DEMOGRAPHIC CHARACTERISTICS 
 
SEX             
   
AGE   
MARITAL STATUS: SINGLE/ MARRIED/DIVORCED/WIDOWED/LIVING WITH 
A PARTNER 
CITIZENSHIP         
 














18-30 31-40 41-50  51-60 









DATE OF INTERVIEW                       -------------------------------------- 
INTERVIEWER’S NAME                    -------------------------------------- 
TIME OF INTERVIEW                        ----------------------------am/pm (please 
tick) 
NAME OF AREA                                 --------------------------------------- 
NAME F NEA S  CLINIC           --------------------------------------- 
HOUSEHOLD NUMBER                    --------------------------------------- 
ID STUDY NUMBER 
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EMPLOYMENT STATUS:  
EMPLOYED IN FORMAL SECTOR / EMPLOYED IN INFORMAL SECTOR/ 
UNEMPLOYED/ SELF- EMPLOYED/ HOUSEWIFE/ STUDENT 
 
 










MONTHLY INDIVIDUAL INCOME – (circle) 
-99/ 100- 999 /1000-1999/ 2000- 2999/ 3000-3999/ 4000-4999/ 5000 and above 
MONTHLY HOUSEHOLD INCOME- 0-99/ 100- 999 /1000-1999/ 2000- 2999/ 
3000-3999/ 4000-4999/ 5000 and above 
HOW much is spent on? 
 Food                                  ------- 
Clothing                              ------- 
 Education                          ------- 
Medical expenses              -------- 
Other please specify-------------------------------------------- 
ARE YOU RECEIVING ANY SOCIAL GRANT?  Yes/No 
FULL TIME PART TIME 
1.Managerial job                       ------------- 
2.Administrative job                 ------------- 
3.Mining and Mineral Industry  ------------ 
4.Education sector              ------------ 
5.Factory and textile industry     ------------ 
6.Health industry                         ------------ 
 
7.Retail industry                 ------------- 
8.Road and Traffic sector           ------------- 
9.Transportation Industry           ------------ 
10.Agriculture and Forestry         -------------- 
11.Domestic work                        --------------- 
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Please specify which one: 
Child support 
Old age pension 
Disability grant 
Other (please specify) 
RESIDENCE – OWN HOUSE/RENTAL/ INFORMAL SETTLEMENT/OTHER 
WHAT IS YOUR HOUSE BUILT?  Brick/ Wood/Mud/Cardboard/Tin/Other 
HOW MANY PEOPLE LIVE IN THE HOUSE? ----------- 
HOW MANY SLEEPING ROOMS?                 ----------------- 
AREA- RURAL---- SEMI-URBAN------- URBAN------------ 
  
 
Access to water supply -  
 
 Type of sewage system  
 
In the last six months  Have you ever gone to bed without food; because you could 
not afford it?  
OFTEN/SOMETIMES/NEVER 
In the last six months Have your child/children gone to bed without food because you 
could not afford? 
OFTEN/SOMETIMES/NEVER 
Alcohol intake     
Current 
Consumption levels:  Heavy/  moderate/ small amounts 
Past alcohol intake Yes/No 





will be used 
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Smoking            Yes/ No  
current 
No. of cigarettes per day?--------------- 
Have you ever smoked in the past? Yes/No 
Illegal Drug use        Often /   Occasionally/Never                                      
Type of drugs    Injectable/ pill /dagga  
Have you ever used drugs in the past? Yes/ No 
Have you developed drug addiction?    Yes/No   
How far is your nearest clinic in kilometres from your home?          ----------------------- 
Do you usally walk to the clinicl?  YES/NO 
If you use transport to get to the clinic what is the Mode of transport?   Own 
transport/ taxi/ bus/ other(please specify)-------------------------------------------- 
How much does it cost to get there and back?          ------------------------------------- 
Is it expensive for you? Yes/No 
Tick () 
Have ever been counselled for HIV 
Have you ever been tested for HIV?            
 
If yes wha was the result? 
HIVPositive/ HIVNegative (circle one response) 
Have you ever been put on long term antibiotics, such as bactrim/cotrimoxazole 
Yes/No/ Not sure 
If positive are you on ARV treatment yet?  Yes/ No 




Yes  No 
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If yes what?                        ------------------------------------------------------------- 
How does someone get TB? 
(Tick () respondent’s answer for UNPROMPTED                                                                                                      
RESPONSE UNPROMPTED PROMPTED 
1.Germ in the air  YES/NO/Don’t know 
2.Living in a crowded house  YES/NO/Don’t know 
3.Staying in a dirty place  YES/NO/Don’t know 
4.Poisoning  YES/NO/Don’t know 
5.Eat/drink something  YES/NO/Don’t know 
6.Eating or drinking leftovers from sick 
person 
 YES/NO/Don’t know 
7.Spit on the ground  YES/NO/Don’t know 
8.From another person who has TB  YES/NO/Don’t know 
9.Smoking   YES/NO/Don’t know 
10.Drinking alcohol  YES/NO/Don’t know 
11.Witchcraft/evil spirit/curse  YES/NO/Don’t know 
12. Other (specify)   
How would you know if someone had TB? 
    (Tick () respondent’s answer for UNPROMPTED                                                                                                      
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Signs and Symptoms UNPROMPTED PROMPTED 
1.Cough> 2 weeks  Yes/No/Don’t know 
2.Coughing up blood  Yes/No/Don’t know 
3.Loss of appetite  Yes/No/Don’t know 
4.Night sweats  Yes/No/Don’t know 
5.Tired-no energy  Yes/No/Don’t know 
6.Chest pain  Yes/No/Don’t know 
7.Shortness of breath  Yes/No/Don’t know 
8.Fever and chills  Yes/No/Don’t know 
9.Other ( please specify)   
How did you get this knowledge? 
(Tick () 
 Friend                   ---------------- 
School teacher      ---------------- 
Partner                  ----------------- 
Television              ---------------- 
Radio                      ----------------- 
Newspaper             ----------------- 
 Pamphlet               ----------------- 
Health worker         ----------------- 
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Other ( please specify)-------------------------------- 
Can TB be cured? (circle one response) Yes/ No/ Don’t know 
Do you know of anyone who has been cured of TB? 
 (circle one response) Yes/ No/ Don’t know 
The quality of care received at the clinic is good    
    (Tick ()     
 
 
Did you complete full TB treatment ( Six months) 
(Please circle) 
Yes/No 
Is the evidence of completion of treatment on your TB card?  
Yes/ No/ Don’t know 
What TB drugs were you taking? 
(Tick () respondent’s answer for UNPROMPTED ( do not offer suggestions) for 
PROMPTED  circle one option                                                                                                   
NAME OF DRUG UNPROMPTED PROMPTED 
RIFAFOUR YES Yes/ Do’t know. 
RIFINAH YES Yes/  Do’t know. 
Have you been told about the outcome of the treatment? 
Yes /No 
Are you cured from TB? 
Yes / No 
( Interviewer will confirm status from the card ot TB register) 
No Yes Neutral 
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What motivated you to finish the six month course of TB treatment? 
1.Will to live  
2.Effectiveness of medication  
3.To retain my job  
4.Seeing others getting better  
5.Other (specify)  
Did you keep your card throughout the treatment period? 
Yes/ No 
 Did you keep all your appointments during the course of treatment?  
Yes /No 
 What was the smear results after two months? 
Negative/ Positive/ Don’t know 
( Interviewer will confirm status from the card ot TB register) 
If you were smear positive, were you tested for MDRTB ? 
Yes/ No 
What was the results? 
Culture positive for MDR/ Not isolated/ Not sure  
Were you ever hospitalised during the course of treatment? 
Yes/No 
Did they change your TB medication to a new one? 
Yes/ No / Not sure 
Did you have DOT support? Yes/No 
If Yes Who is your DOT supporter?-------------------------------------- 






How was your DOT supporter allocated? 
 
 
Frequency of DOT support              
     
 
 
Were you stigmatised for having TB? 
 Yes/No/Not sure (circle one response) 
Did you have any side effects fro the treatment you were taking? 
Yes /No 





4.Painful joints  












Pastor Friend Other (please specify--- 
 Allocated by health worker Own choice 
Other (please 
specify) 
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6.Painful feet  
7.Other (please specify)  
Did you ever have to interrupt treatment ?    
 
 
If yes for how long?                       --------------------------------------- 
Reason for interruption                
 
 
Have you ever stopped taking treatment? 
 Yes/No 
If yes for how long were you on treatment? Less than 1 month/ 1 month/ 2 months/ 3 
months/ 4 months/ Other--------- 






Did you use any alternative medicine together with TB treatment   
If yes, who did you Consult? –Traditional Healer /Diviner / Faith healer/ Homeopath/ 
Other (please specify 
--------------------------------------------- 
What did you use?       
Tick () 
Yes No 
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1.Oral mixture  
2.Emetic  
3.Steam inhalation  
4.Nasal spray  
5.Inhalant  
6.Enema  
7.Holy water  
8.Other (please specify)  
Did it work?  Yes/ No/ Do’t know 
If Yes how did it work? 
Tick () 
1.Relieved cough  
2.Restored anergy  
3.Treated night sweats  
4.Restored appetite  
5.Other (please specify)  
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How was your health been during treatment?                           
 
 
Did you carry on work while having TB treatment?    
1.All the time  
2.Sick leave  
3.Dismissed from work  
4.Stopped voluntarily  
 5.Other (specify)  
Has anyone living with you in recently been treated for TB? 
Yes/ No/ Don’t know (circle) 
THANK YOU FOR YOUR TIME AND PARTICIPATION 
Signature of interviewer__________________ Signature of 
Supervisor:________________ 
Date:_________________              Date ___________________ 
  
Very ill fairly ill                    Very well reasonably well 
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APPENDIX B CONSENT DOCUMENT (ENGLISH) 
THE CONTRIBUTION OF PATIENT-RELATED FACTORS TO IN THE 
TUBERCULOSIS TB TREATMENT OUTCOMES. A CASE-CONTROL STUDY- 
  UMGUNGUNDLOVU DISTRICT 
Consent to Participate in Research 
You have been asked to participate in a research study. 
You have been informed about the study by Mrs. Z. Ndwandwe. 
Where applicable: You have been informed about any available compensation or 
medical treatment if injury occurs as a result of study-related procedures; 
You may contact Zanele Ndwandwe at 083 460 2593 any time if you have questions 
about the research or if you are injured as a result of the research. 
You may contact the Medical Research Office at the Nelson R Mandela School of 
Medicine at 031-260 4604 if you have questions about your rights as a research 
subject. 
Your participation in this research is voluntary, and you will not be penalized or lose 
benefits if you refuse to participate or decide to stop. 
If you agree to participate, you will be given a signed copy of this document and the 
participant information sheet which is a written summary of the research. 
The research study, including the above information, has been described to 
me orally. I understand what my involvement in the study means and I 
voluntarily agree to participate. 
_________________               ______________ 
 
Signature of Participant                            Date 
 
____________________         ________________ 
Signature of Witness                                Date 
  
 124  
 




 126  
 
APPENDIX 8 
PERMISSION TO CONDUCT A RESEARCH STUDY/TRIAL 
This must be completed and submitted to the Medical Superintendent/s / Hospital Manager for 
signature.    
 
For King Edward VIII Hospital (KEH) and Inkosi Albert Luthuli Central Hospital (IALCH) studies 
please submit together with the following: 
 
i) Two copies of the final, approved protocol 
ii) Letter giving provisional ethical approval 
iii) Details of other research presently being performed by yourself (individually or as a 
collaborator) 
iv) Details of any financial or human resource implications to King Edward VIII Hospital 
v) If a clinical trial, please produce proof of payment or intention thereof to KEH 
 
Once the document has been signed it should be returned to this office so that full ethical 
approval can be granted. 
 
To: District Manager 
PROTOCOL  
THE CONTRIBUTION OF PATIENT-RELATED FACTORS IN TUBERCULOSIS 
TREATMENT OUTCOMES. UMGUNGUNDLOVU DISTRICT- A CASE- CONTROL STUDY. 
Permission is requested to conduct the above research study at the hospital/s indicated below: 
 
Site 1 address: Investigator/ 
15 Clinics in Umgungundlovu Health District.    Principal: Z.S.I Ndwandwe 
                                                                         Co-investigator:_____________________ 
                                                              Co-Investigator: _____________________ 
Signature of District Manager:  
 
 
Site 2 address: Investigator/s 
_______________________________ Principal: __________________________ 
_______________________________ Co-investigator: _____________________ 
_______________________________ Co-Investigator: _____________________ 
Signature of Hospital Manager : 
________________________ Date: _________________________ 
NB:  Hospital Manager/s to send a copy of this document to Natalia. 
